{"medgen_id":"C0344911","xrefs":[],"name":"Dilated left ventricle","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"40607","attribute_content":[],"keywords":[]}
{"medgen_id":"CN236805","xrefs":[],"name":"Caused by mutation in the TBC1 domain family, member 24","alternate_symbols":[],"type":"Finding","alternate_names":[],"id":"35670","attribute_content":[],"keywords":[]}
{"medgen_id":"CN276904","xrefs":[],"name":"Caused by mutation in the tafazzin gene","alternate_symbols":[],"type":"Finding","alternate_names":[],"id":"37949","attribute_content":[],"keywords":[]}
{"medgen_id":"C3658299","xrefs":[],"name":"Zellweger Spectrum Disorder","alternate_symbols":[],"type":"Disease","alternate_names":["Zellweger Spectrum"],"id":"43022","attribute_content":[],"keywords":[]}
{"medgen_id":"CN225662","xrefs":[],"name":"Pulmonary valve stenosis (rare)","alternate_symbols":[],"type":"Finding","alternate_names":[],"id":"32695","attribute_content":[],"keywords":[]}
{"medgen_id":"C0751587","xrefs":["{\"db\":\"Orphanet\",\"id\":\"136\"}","{\"db\":\"OMIM\",\"id\":\"125310\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DEMENTIA, HEREDITARY MULTIINFARCT TYPE\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000071627\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CADASIL1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"CADASIL/1013\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"390936003\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1500\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"125310\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy","symbol":"CADASIL","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301673\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1500\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["CADASIL1"],"public_definition":"CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is characterized by mid-adult onset of recurrent ischemic stroke, cognitive decline progressing to dementia, a history of migraine with aura, mood disturbance, apathy, and diffuse white matter lesions and subcortical infarcts on neuroimaging.","type":"Disease","alternate_names":["DEMENTIA, HEREDITARY MULTIINFARCT TYPE"],"id":"43267","attribute_content":[],"keywords":[]}
{"medgen_id":"C1861864","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007266\"}","{\"db\":\"OMIM\",\"id\":\"115195\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+hypertrophic+cardiomyopathy+2/8391\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"familial-hypertrophic-cardiomyopathy\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"115195\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Familial hypertrophic cardiomyopathy 2","symbol":"CMH2","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301725\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1768\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21267010\",\"@Source\":\"PubMed\"}}]}","alternate_symbols":["KFS"],"public_definition":"Familial hypertrophic cardiomyopathy is a heart condition characterized by thickening (hypertrophy) of the heart (cardiac) muscle. Thickening usually occurs in the interventricular septum, which is the muscular wall that separates the lower left chamber of the heart (the left ventricle) from the lower right chamber (the right ventricle). In some people, thickening of the interventricular septum impedes the flow of oxygen-rich blood from the heart, which may lead to an abnormal heart sound during a heartbeat (heart murmur) and other signs and symptoms of the condition. Other affected individuals do not have physical obstruction of blood flow, but the pumping of blood is less efficient, which can also lead to symptoms of the condition. Cardiac hypertrophy often begins in adolescence or young adulthood, although it can develop at any time throughout life.The symptoms of familial hypertrophic cardiomyopathy are variable, even within the same family. Many affected individuals have no symptoms. Other people with familial hypertrophic cardiomyopathy may experience chest pain; shortness of breath, especially with physical exertion; a sensation of fluttering or pounding in the chest (palpitations); lightheadedness; dizziness; and fainting.While most people with familial hypertrophic cardiomyopathy are symptom-free or have only mild symptoms, this condition can have serious consequences. It can cause abnormal heart rhythms (arrhythmias) that may be life threatening. People with familial hypertrophic cardiomyopathy have an increased risk of sudden death, even if they have no other symptoms of the condition. A small number of affected individuals develop potentially fatal heart failure, which may require heart transplantation.","type":"Disease","alternate_names":["TNNT2-Related Familial Hypertrophic Cardiomyopathy"],"id":"679","attribute_content":[],"keywords":[]}
{"medgen_id":"C0007286","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007275\"}","{\"db\":\"OMIM\",\"id\":\"115430\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AMYOTROPHY, THENAR, OF CARPAL ORIGIN\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Carpal+tunnel+syndrome/7908\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"carpal-tunnel-syndrome\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"115430\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Carpal tunnel syndrome","symbol":"CTS","alternate_symbols":[],"public_definition":"Carpal tunnel syndrome is a disorder caused by disturbances in nerve function (neuropathy), leading to pain and numbness or tingling (paresthesia) primarily in the wrist and hand. While carpal tunnel syndrome can occur at any age, it most often affects people between the ages of 40 and 60. In more than half of cases, both hands are affected; however, the severity may vary between hands. When only one hand is affected, it is most often the hand used for writing (the dominant hand).In carpal tunnel syndrome, the pain or paresthesia is usually felt in the wrist, the palm, and the first four fingers of the hand. These signs and symptoms often develop during sleep and are noticeable upon waking. Affected individuals typically shake their hand to get rid of the pain and numbness, a characteristic move known as the flick sign. As the condition advances, the signs and symptoms begin to occur during the day as well. Affected individuals may have difficulty performing manual tasks such as turning doorknobs, fastening buttons, or opening jars. The symptoms of carpal tunnel syndrome may be triggered by certain activities that flex or extend the wrist, such as driving, typing, or holding a telephone.Over time, people with carpal tunnel syndrome can have muscle and nerve wasting (atrophy) in the affected hand and a reduced ability to detect sensations, which can be mistaken for an improvement of symptoms.","type":"Disease","alternate_names":["AMYOTROPHY, THENAR, OF CARPAL ORIGIN"],"id":"687","attribute_content":[],"keywords":[]}
{"medgen_id":"C5235211","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008086\"}","{\"db\":\"OMIM\",\"id\":\"162400\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"162400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSAN IA\"}","{\"db\":\"OMIM\",\"id\":\"162400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSN IA\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1390\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hereditary Sensory Neuropathy Type IA\"}","{\"db\":\"OMIM\",\"id\":\"162400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA\"}","{\"db\":\"OMIM\",\"id\":\"162400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL DOMINANT, TYPE 1A\"}","{\"db\":\"OMIM\",\"id\":\"162400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HSN1A\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008086\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1390\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"162400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Neuropathy, hereditary sensory and autonomic, type 1A","symbol":"HSAN1A","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301564\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1390\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["HSN1A"],"public_definition":"SPTLC1-related hereditary sensory neuropathy (HSN) is an axonal form of hereditary motor and sensory neuropathy distinguished by prominent early sensory loss and later positive sensory phenomena including dysesthesia and characteristic \"lightning\" or \"shooting\" pains. Loss of sensation can lead to painless injuries, which, if unrecognized, result in slow wound healing and subsequent osteomyelitis requiring distal amputations. Motor involvement is present in all advanced cases and can be severe. After age 20 years, the distal wasting and weakness may involve proximal muscles, possibly leading to wheelchair dependency by the seventh or eighth decade. Sensorineural hearing loss is variable.","type":"Disease","alternate_names":["HSAN IA","HSN IA","Hereditary Sensory Neuropathy Type IA","NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA","NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL DOMINANT, TYPE 1A"],"id":"53769","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393125","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008394\"}","{\"db\":\"OMIM\",\"id\":\"180860\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"813\"}","{\"db\":\"OMIM\",\"id\":\"180860\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"RSS\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000327158\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SRS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4870\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Silver-Russell+syndrome/6606\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"russell-silver-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"15069006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1324\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"180860\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Russell-Silver syndrome","symbol":"SRS1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301499\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1324\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111049\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3061987\",\"@Source\":\"pmc\"}}]}","alternate_symbols":["RSS","SRS"],"public_definition":"Silver-Russell Syndrome (SRS) is typically characterized by asymmetric gestational growth restriction resulting in affected individuals being born small for gestational age, with relative macrocephaly at birth (head circumference =1.5 SD above birth weight and/or length), prominent forehead usually with frontal bossing, and frequently body asymmetry. This is followed by postnatal growth failure, and in some cases progressive limb length discrepancy and feeding difficulties. Additional clinical features include triangular facies, fifth-finger clinodactyly, and micrognathia with narrow chin. Except for the limb length asymmetry, the growth failure is proportionate and head growth normal. The average adult height in untreated individuals is ~3.1±1.4 SD below the mean. The Netchine-Harbison Clinical Scoring System (NH-CSS) is a sensitive diagnostic scoring system. Clinical diagnosis can be established in an individual who meets at least four of the NH-CSS clinical criteria – prominent forehead/frontal bossing and relative macrocephaly at birth plus two additional findings – and in whom other disorders have been ruled out.","type":"Disease","alternate_names":["Silver-Russell dwarfism"],"id":"15879","attribute_content":[],"gard_id":"4870","keywords":[]}
{"medgen_id":"C1321551","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008426\"}","{\"db\":\"OMIM\",\"id\":\"182212\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2462\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Shprintzen-Goldberg+craniosynostosis+syndrome/6581\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"shprintzen-goldberg-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"83092002\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1277\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"182212\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Shprintzen-Goldberg syndrome","symbol":"SGS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301454\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1277\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Shprintzen-Goldberg syndrome (SGS) is characterized by: delayed motor and cognitive milestones and mild-to-moderate intellectual disability; craniosynostosis of the coronal, sagittal, or lambdoid sutures; distinctive craniofacial features; and musculoskeletal findings including olichostenomelia, arachnodactyly, camptodactyly, pectus excavatum or carinatum, scoliosis, joint hypermobility or contractures, pes planus, foot malposition, and C1-C2 spine malformation. Cardiovascular anomalies may include mitral valve prolapse, secundum atrial septal defect, and aortic root dilatation. Minimal subcutaneous fat, abdominal wall defects, and myopia are also characteristic findings.","type":"Disease","alternate_names":["Craniosynostosis with arachnodactyly and abdominal hernias","Marfanoid craniosynostosis syndrome","Marfanoid disorder with craniosynostosis type 1","Shprintzen-Goldberg craniosynostosis syndrome","Shprintzen-Goldberg marfanoid syndrome"],"id":"5914","attribute_content":[],"keywords":[]}
{"medgen_id":"C5201146","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008523\"}","{\"db\":\"OMIM\",\"id\":\"186580\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"90340\"}","{\"db\":\"OMIM\",\"id\":\"186580\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ACUG\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Synovitis+granulomatous+with+uveitis+and+cranial+neuropathies/6974\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"blau-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"186580\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Blau syndrome","symbol":"BLAUS","alternate_symbols":["ACUG"],"type":"Disease","alternate_names":["Arthrocutaneouveal granulomatosis","Granulomatosis, familial juvenile systemic","Granulomatosis, familial, Blau type","Granulomatous inflammatory arthritis, dermatitis, and uveitis, familial","Jabs syndrome","Synovitis granulomatous with uveitis and cranial neuropathies"],"id":"4676","attribute_content":[],"keywords":[]}
{"medgen_id":"C0751383","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008767\"}","{\"db\":\"OMIM\",\"id\":\"204200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"228346\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008767\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"204200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Neuronal ceroid lipofuscinosis 3","symbol":"CLN3","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301601\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1428\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"type":"Disease","alternate_names":["CLN3 Disease","CLN3-Related Neuronal Ceroid-Lipofuscinosis","Spielmeyer Sjogren disease"],"id":"768","attribute_content":[],"keywords":[]}
{"medgen_id":"C1857662","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008996\"}","{\"db\":\"OMIM\",\"id\":\"216360\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1454\"}","{\"db\":\"OMIM\",\"id\":\"216360\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBELLAR VERMIS HYPO/APLASIA, OLIGOPHRENIA, CONGENITAL ATAXIA, OCULAR COLOBOMA, AND HEPATIC FIBROSIS\"}","{\"db\":\"OMIM\",\"id\":\"216360\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COACH SYNDROME 1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"COACH+Syndrome/1692\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COACH syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1410\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008996\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"216360\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Joubert syndrome with hepatic defect","symbol":"COACH1","content":"{\"Citation\":{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21448235\",\"@Source\":\"PubMed\"}}}","alternate_symbols":["CC2D2A"],"type":"Disease","alternate_names":["CEREBELLAR VERMIS HYPO/APLASIA, OLIGOPHRENIA, CONGENITAL ATAXIA, OCULAR COLOBOMA, AND HEPATIC FIBROSIS","COACH SYNDROME 1","COACH syndrome","Cerebellar vermis hypo/aplasia, Oligophrenia, Ataxia congenital, Coloboma, and Hepatic fibrosis","Joubert syndrome with congenital hepatic fibrosis"],"id":"821","attribute_content":[],"gard_id":"1410","keywords":[]}
{"medgen_id":"C5234852","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009053\"}","{\"db\":\"OMIM\",\"id\":\"219150\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2962\"}","{\"db\":\"Orphanet\",\"id\":\"35664\"}","{\"db\":\"OMIM\",\"id\":\"219150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DE BARSY SYNDROME A\"}","{\"db\":\"OMIM\",\"id\":\"219150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Cutis laxa, autosomal recessive IIIA","symbol":"ARCL3A","alternate_symbols":[],"type":"Disease","alternate_names":["DE BARSY SYNDROME A"],"id":"917","attribute_content":[],"keywords":[]}
{"medgen_id":"C5234880","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009465\"}","{\"db\":\"OMIM\",\"id\":\"243150\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2300\"}","{\"db\":\"Orphanet\",\"id\":\"436252\"}","{\"db\":\"Orphanet\",\"id\":\"436252\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Combined immunodeficiency-enteropathy spectrum\"}","{\"db\":\"OMIM\",\"id\":\"243150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"609332.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"243150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTESTINAL ATRESIA, MULTIPLE AND/OR INFLAMMATORY BOWEL DISEASE WITH OR WITHOUT IMMUNODEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"243150\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FIPA\"}","{\"db\":\"OMIM\",\"id\":\"243150\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MINAT\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3013\",\"ref_field\":\"gard_id\"}","{\"db\":\"SNOMED CT\",\"id\":\"95472001\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"243150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Multiple gastrointestinal atresias","symbol":"GIDID","alternate_symbols":["FIPA","MINAT"],"type":"Disease","alternate_names":["Combined immunodeficiency-enteropathy spectrum","Familial intestinal polyatresia syndrome","GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME","INTESTINAL ATRESIA, MULTIPLE AND/OR INFLAMMATORY BOWEL DISEASE WITH OR WITHOUT IMMUNODEFICIENCY","Intestinal atresia multiple"],"id":"2485","attribute_content":[],"gard_id":"3013","keywords":[]}
{"medgen_id":"C3151513","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009636\"}","{\"db\":\"OMIM\",\"id\":\"251880\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"279934\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mitochondrial+DNA-depletion+syndrome+3%2C+hepatocerebral/8901\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK7040\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"251880\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Mitochondrial DNA-depletion syndrome 3, hepatocerebral","symbol":"MTDPS3","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301766\",\"@Source\":\"PubMed\"},{\"$\":\"NBK7040\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29517884\",\"@Source\":\"PubMed\"},{\"$\":\"NBK487393\",\"@Source\":\"BookShelf\"}]}]}","alternate_symbols":[],"public_definition":"The two forms of deoxyguanosine kinase (DGUOK) deficiency are a neonatal multisystem disorder and an isolated hepatic disorder that presents later in infancy or childhood. The majority of affected individuals have the multisystem illness with hepatic disease (jaundice, cholestasis, hepatomegaly, and elevated transaminases) and neurologic manifestations (hypotonia, nystagmus, and psychomotor retardation) evident within weeks of birth. Those with isolated liver disease may also have renal involvement and some later develop mild hypotonia. Progressive hepatic disease is the most common cause of death in both forms.","type":"Disease","alternate_names":[],"id":"15712","attribute_content":[],"keywords":[]}
{"medgen_id":"C1829703","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009705\"}","{\"db\":\"OMIM\",\"id\":\"255120\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"156\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1527\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Carnitine Palmitoyltransferase IA Deficiency\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009705\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Carnitine palmitoyl transferase 1A deficiency\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Carnitine+Palmitoyl+Transferase+1+Deficiency/1109\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Carnitine palmitoyltransferase I deficiency\"}","{\"db\":\"SNOMED CT\",\"id\":\"238001003\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Carnitine palmitoyltransferase I deficiency\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1120\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneTests\",\"id\":\"68896\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1527\",\"ref_field\":\"public_definition\"}"],"name":"Carnitine palmitoyltransferase 1A deficiency","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301700\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1527\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a disorder of long-chain fatty acid oxidation. Clinical manifestations usually occur in an individual with a concurrent febrile or gastrointestinal illness when energy demands are increased; onset of symptoms is usually rapid. The recognized phenotypes are: acute fatty liver of pregnancy, in which the fetus has biallelic pathogenic variants in CPT1A that causes CPT1A deficiency; and hepatic encephalopathy, in which individuals (typically children) present with hypoketotic hypoglycemia and sudden onset of liver failure. Individuals with hepatic encephalopathy typically present with hypoglycemia, absent or low levels of ketones, and elevated serum concentrations of liver transaminases, ammonia, and total carnitine. Between episodes of hepatic encephalopathy, individuals appear developmentally and cognitively normal unless previous metabolic decompensation has resulted in neurologic damage.","type":"Disease","alternate_names":["CPT1A deficiency","Carnitine Palmitoyltransferase IA Deficiency","Carnitine palmitoyl transferase 1 deficiency","Carnitine palmitoyl transferase 1A deficiency","Carnitine palmitoyltransferase I deficiency","Hepatic CPT1","Hepatic carnitine palmitoyltransferase 1 deficiency","L-CPT 1 deficiency"],"id":"8237","attribute_content":[],"gard_id":"1120","keywords":[]}
{"medgen_id":"C0265962","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009735\"}","{\"db\":\"OMIM\",\"id\":\"256500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"634\"}","{\"db\":\"OMIM\",\"id\":\"256500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COMEL-NETHERTON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"256500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ERYTHRODERMA, ICHTHYOSIFORM, WITH HYPOTRICHOSIS AND HYPER-IgE\"}","{\"db\":\"OMIM\",\"id\":\"256500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Netherton+syndrome/5152\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"netherton-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"256500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Netherton syndrome","symbol":"NETH","alternate_symbols":["NS"],"type":"Disease","alternate_names":["COMEL-NETHERTON SYNDROME","ERYTHRODERMA, ICHTHYOSIFORM, WITH HYPOTRICHOSIS AND HYPER-IgE","Netherton disease"],"id":"5626","attribute_content":[],"keywords":[]}
{"medgen_id":"C1849437","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0009964\"}","{\"db\":\"OMIM\",\"id\":\"266920\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"140969\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Renal+dysplasia%2C+retinal+pigmentary+dystrophy%2C+cerebellar+ataxia+and+skeletal+dysplasia/6203\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia\"}","{\"db\":\"SNOMED CT\",\"id\":\"254092004\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia\"}","{\"db\":\"OMIM\",\"id\":\"266920\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"614620.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY\"}","{\"db\":\"OMIM\",\"id\":\"266920\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MZSDS\"}","{\"db\":\"SNOMED CT\",\"id\":\"254092004\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"266920\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Saldino-Mainzer syndrome","symbol":"SRTD9","alternate_symbols":["MZSDS"],"type":"Disease","alternate_names":["Conorenal syndrome","Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia","SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY","SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY"],"id":"3600","attribute_content":[],"keywords":[]}
{"medgen_id":"C1959620","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010130\"}","{\"db\":\"OMIM\",\"id\":\"274270\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1675\"}","{\"db\":\"OMIM\",\"id\":\"274270\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DPYD DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Dihydropyrimidine+Dehydrogenase+Deficiency/2282\",\"ref_field\":\"name\"}"],"name":"Dihydropyrimidine dehydrogenase deficiency","content":"{\"Citation\":[{\"@Abbrev\":\"CPIC, 2017\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"29152729\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"DailyMed Drug Label, 2012\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"DailyMed Drug Label, ADRUCIL, 2012\"},\"URL\":{\"$\":\"https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac\"}}]}","alternate_symbols":[],"type":"Disease","alternate_names":["DPD deficiency","DPYD DEFICIENCY","Hereditary Thymine-Uraciluria","Pyrimidinemia familial"],"id":"1107","attribute_content":[],"keywords":[]}
{"medgen_id":"C0023374","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010298\"}","{\"db\":\"OMIM\",\"id\":\"300322\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"510\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Lesch+Nyhan+syndrome/4181\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"lesch-nyhan-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"10406007\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1149\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300322\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Lesch-Nyhan syndrome","symbol":"LNS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301328\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1149\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111012\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3039492\",\"@Source\":\"pmc\"}}]}","alternate_symbols":[],"public_definition":"HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.","type":"Disease","alternate_names":["Hypoxanthine guanine phospho-ribosyltransferase 1 deficiency","Hypoxanthine guanine phosphoribosyltransferase deficiency"],"id":"5397","attribute_content":[],"keywords":[]}
{"medgen_id":"C0175701","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010589\"}","{\"db\":\"OMIM\",\"id\":\"305400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"915\"}","{\"db\":\"OMIM\",\"id\":\"300546.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER\"}","{\"db\":\"OMIM\",\"id\":\"300546.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER\"}","{\"db\":\"OMIM\",\"id\":\"305400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FGDY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Aarskog+Syndrome/58\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"14921002\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"305400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Aarskog syndrome","symbol":"AAS","content":"{\"Citation\":{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21654724\",\"@Source\":\"PubMed\"}}}","alternate_symbols":[],"type":"Disease","alternate_names":["AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER","Aarskog Scott syndrome","Aarskog disease","FGDY"],"id":"15926","attribute_content":[],"keywords":[]}
{"medgen_id":"C0019069","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010602\"}","{\"db\":\"OMIM\",\"id\":\"306700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98878\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1404\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hemophilia A\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+factor+VIII+deficiency+disease/8517\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"28293008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1404\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"306700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Hereditary factor VIII deficiency disease","symbol":"HEMA","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301578\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1404\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21654722\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"UKHCDO, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23157203\",\"@Source\":\"PubMed\"}}]}","alternate_symbols":[],"public_definition":"Hemophilia A is characterized by deficiency in factor VIII clotting activity that results in prolonged oozing after injuries, tooth extractions, or surgery, and delayed or recurrent bleeding prior to complete wound healing. The age of diagnosis and frequency of bleeding episodes are related to the level of factor VIII clotting activity. Individuals with severe hemophilia A are usually diagnosed during the first two years of life following bleeding from minor mouth injuries and large \"goose eggs\" from minor head bumps. Without prophylactic treatment, they may average up to two to five spontaneous bleeding episodes each month including spontaneous joint bleeds or deep-muscle hematomas, and prolonged bleeding or excessive pain and swelling from minor injuries, surgery, and tooth extractions. Individuals with moderate hemophilia A seldom have spontaneous bleeding; however, they do have prolonged or delayed oozing after relatively minor trauma and are usually diagnosed before age five to six years; the frequency of bleeding episodes varies, usually from once a month to once a year. Individuals with mild hemophilia A do not have spontaneous bleeding episodes; however, without pre- and postoperative treatment, abnormal bleeding occurs with surgery or tooth extractions; the frequency of bleeding episodes varies widely, typically from once a year to once every ten years. Individuals with mild hemophilia A are often not diagnosed until later in life. Approximately 30% of heterozygous females have clotting activity below 40% and are at risk for bleeding (even if the affected family member is mildly affected). After major trauma or invasive procedures, prolonged or excessive bleeding usually occurs, regardless of severity.","type":"Disease","alternate_names":["Factor 8 deficiency, congenital","Factor VIII deficiency, congenital","HEM A","Hemophilia A","Hemophilia A, congenital","Hemophilia, classic"],"id":"2126","attribute_content":[],"keywords":[]}
{"medgen_id":"C0751337","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010680\"}","{\"db\":\"OMIM\",\"id\":\"310300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"261\"}","{\"db\":\"Orphanet\",\"id\":\"98863\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Emery-Dreifuss+Muscular+Dystrophy%2C+X-Linked/2512\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Emery-Dreifuss muscular dystrophy, X-linked\"}","{\"db\":\"SNOMED CT\",\"id\":\"784352007\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"X-linked scapuloperoneal muscular dystrophy\"}","{\"db\":\"OMIM\",\"id\":\"310300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EMD1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Emery-Dreifuss+Muscular+Dystrophy/2510\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1436\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"310300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Emery-Dreifuss muscular dystrophy 1, X-linked","symbol":"EDMD1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301609\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1436\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["EMD1"],"public_definition":"Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure along with variable cardiac rhythm disturbances. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade and respiratory function may be impaired in some individuals.","type":"Disease","alternate_names":["EMD-Related Cardiomyopathy","Emery-Dreifuss muscular dystrophy, X-linked","Muscular dystrophy, tardive Emery-Dreifuss type, with contractures","X-linked scapuloperoneal muscular dystrophy"],"id":"15903","attribute_content":[],"keywords":[]}
{"medgen_id":"C0262436","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0010753\"}","{\"db\":\"OMIM\",\"id\":\"314400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1864\"}","{\"db\":\"Orphanet\",\"id\":\"75497\"}","{\"db\":\"OMIM\",\"id\":\"314400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XMVD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cardiac+Valvular+Dysplasia%2C+X-Linked/1082\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"314400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Cardiac valvular dysplasia, X-linked","symbol":"CVD1","alternate_symbols":["XMVD"],"type":"Disease","alternate_names":["Myxomatous valvular dystrophy, X-linked","Valvular heart disease, congenital"],"id":"711","attribute_content":[],"keywords":[]}
{"medgen_id":"C1832680","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011003\"}","{\"db\":\"OMIM\",\"id\":\"601154\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"154\"}","{\"db\":\"OMIM\",\"id\":\"601154\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT 2\"}","{\"db\":\"OMIM\",\"id\":\"601154\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, DILATED, WITH CONDUCTION DISORDER AND ARRHYTHMIA\"}","{\"db\":\"OMIM\",\"id\":\"601154\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDCD2\"}","{\"db\":\"OMIM\",\"id\":\"601154\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Dilated cardiomyopathy 1E","symbol":"CMD1E","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301486\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1309\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["CDCD2"],"type":"Disease","alternate_names":["CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT 2","CARDIOMYOPATHY, DILATED, WITH CONDUCTION DISORDER AND ARRHYTHMIA","SCN5A-Associated Dilated Cardiomyopathy"],"id":"4730","attribute_content":[],"keywords":[]}
{"medgen_id":"C0410180","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011271\"}","{\"db\":\"OMIM\",\"id\":\"602771\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602771\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MDRS1\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"rigid-spine-muscular-dystrophy\",\"ref_field\":\"ghr_links\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Eichsfeld+type+congenital+muscular+dystrophy/8301\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"240063002\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602771\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Eichsfeld type congenital muscular dystrophy","symbol":"RSMD1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301467\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1290\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"Int'l SCC for CMD, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21078917\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301468\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1291\",\"@Source\":\"BookShelf\"}]}]}","alternate_symbols":["MDRS1","SEPN1-RM"],"type":"Disease","alternate_names":["Desmin-related myopathies with Mallory bodies","Minicore myopathy, severe classic form","Multicore myopathy, severe classic form","Multiminicore disease, severe classic form","Muscular dystrophy, congenital, merosin positive with early spine rigidity","Rigid spine muscular dystrophy-1"],"id":"4109","attribute_content":[],"ghr_links":"rigid spine muscular dystrophy","keywords":[]}
{"medgen_id":"C1864233","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011281\"}","{\"db\":\"OMIM\",\"id\":\"603034\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"590\"}","{\"db\":\"OMIM\",\"id\":\"603033.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603033.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603034\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYASTHENIC SYNDROME, CONGENITAL, 5\"}","{\"db\":\"OMIM\",\"id\":\"603034\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EAD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Endplate+acetylcholinesterase+deficiency/8313\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1168\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"603034\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Endplate acetylcholinesterase deficiency","symbol":"CMS5","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301347\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1168\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["EAD"],"public_definition":"Congenital myasthenic syndromes (designated as CMS throughout this entry) are characterized by fatigable weakness of skeletal muscle (e.g., ocular, bulbar, limb muscles) with onset at or shortly after birth or in early childhood; rarely, symptoms may not manifest until later in childhood. Cardiac and smooth muscle are usually not involved. Severity and course of disease are highly variable, ranging from minor symptoms to progressive disabling weakness. In some subtypes of CMS, myasthenic symptoms may be mild, but sudden severe exacerbations of weakness or even sudden episodes of respiratory insufficiency may be precipitated by fever, infections, or excitement. Major findings of the neonatal-onset subtype include: respiratory insufficiency with sudden apnea and cyanosis; feeding difficulties; poor suck and cry; choking spells; eyelid ptosis; and facial, bulbar, and generalized weakness. Arthrogryposis multiplex congenita may also be present. Stridor in infancy may be an important clue to CMS. Later childhood-onset subtypes show abnormal muscle fatigability with difficulty in activities such as running or climbing stairs; motor milestones may be delayed; fluctuating eyelid ptosis and fixed or fluctuating extraocular muscle weakness are common presentations.","type":"Disease","alternate_names":["MYASTHENIC SYNDROME, CONGENITAL, 5"],"id":"1153","attribute_content":[],"keywords":[]}
{"medgen_id":"C1863557","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011365\"}","{\"db\":\"OMIM\",\"id\":\"603736\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3047\"}","{\"db\":\"OMIM\",\"id\":\"603736\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OHDO SYNDROME, SBBYS VARIANT\"}","{\"db\":\"OMIM\",\"id\":\"603736\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"605880.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"605880.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"605880.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"605880.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"605880.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"605880.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"605880.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Young+Simpson+syndrome/7589\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Young Simpson syndrome\"}","{\"db\":\"OMIM\",\"id\":\"603736\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"YSS\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011365\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK114806\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"603736\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Blepharophimosis - intellectual disability syndrome, SBBYS type","symbol":"SBBYSS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23236640\",\"@Source\":\"PubMed\"},{\"$\":\"NBK114806\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["YSS"],"public_definition":"KAT6B disorders include genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome (SBBYSS) which are part of a broad phenotypic spectrum with variable expressivity; individuals presenting with a phenotype intermediate between GPS and SBBYSS have been reported. Both phenotypes are characterized by some degree of global developmental delay / intellectual disability; hypotonia; genital abnormalities; and skeletal abnormalities including patellar hypoplasia/agenesis, flexion contractures of the knees and/or hips, and anomalies of the digits, spine, and/or ribs. Congenital heart defects, small bowel malrotation, feeding difficulties, slow growth, cleft palate, hearing loss, and dental anomalies have been observed in individuals with either phenotype.","type":"Disease","alternate_names":["KAT6B-Related Disorders","Mental retardation unusual facies hypothyroidism","OHDO SYNDROME, SBBYS VARIANT","SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME","Say-Barber-Biesecker Variant of Ohdo Syndrome","Say-Barber-Biesecker-Young-Simpson variant of Ohdo Syndrome","Young Simpson syndrome"],"id":"4035","attribute_content":[],"keywords":[]}
{"medgen_id":"C1858391","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011457\"}","{\"db\":\"OMIM\",\"id\":\"PS604391\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\" PS604391\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS604391\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604391\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Ataxia-telangiectasia-like disorder","symbol":"ATLD","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"36734","attribute_content":[],"keywords":[]}
{"medgen_id":"C1834460","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012112\"}","{\"db\":\"OMIM\",\"id\":\"608758\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608758\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, HYPERTROPHIC, MID-LEFT VENTRICULAR CHAMBER TYPE, 2\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+hypertrophic+cardiomyopathy+10/8383\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608758\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Familial hypertrophic cardiomyopathy 10","symbol":"CMH10","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301725\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1768\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21267010\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","alternate_symbols":[],"type":"Disease","alternate_names":["CARDIOMYOPATHY, HYPERTROPHIC, MID-LEFT VENTRICULAR CHAMBER TYPE, 2","MYL2-Related Familial Hypertrophic Cardiomyopathy"],"id":"677","attribute_content":[],"keywords":[]}
{"medgen_id":"C1837355","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012125\"}","{\"db\":\"OMIM\",\"id\":\"608804\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"280270\"}","{\"db\":\"Orphanet\",\"id\":\"280282\"}","{\"db\":\"OMIM\",\"id\":\"608804\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PELIZAEUS-MERZBACHER-LIKE DISEASE, 1\"}","{\"db\":\"OMIM\",\"id\":\"608804\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PMLD1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leukodystrophy%2C+hypomyelinating%2C+2/8740\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK470716\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"608804\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Leukodystrophy, hypomyelinating, 2","symbol":"HLD2","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29276893\",\"@Source\":\"PubMed\"},{\"$\":\"NBK470716\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["PMLD1"],"public_definition":"Pelizaeus-Merzbacher-like disease 1 (PMLD1) is a slowly progressive leukodystrophy that typically presents during the neonatal or early-infantile period with nystagmus, commonly associated with hypotonia, delayed acquisition of motor milestones, speech delay, and dysarthria. Over time the hypotonia typically evolves into spasticity that affects the ability to walk and communicate. Cerebellar signs (gait ataxia, dysmetria, intention tremor, head titubation, and dysdiadochokinesia) frequently manifest during childhood. Some individuals develop extrapyramidal movement abnormalities (choreoathetosis and dystonia). Hearing loss and optic atrophy are observed in rare cases. Motor impairments can lead to swallowing difficulty and orthopedic complications, including hip dislocation and scoliosis. Most individuals have normal cognitive skills or mild intellectual disability – which, however, can be difficult to evaluate in the context of profound motor impairment.","type":"Disease","alternate_names":["PELIZAEUS-MERZBACHER-LIKE DISEASE, 1"],"id":"5404","attribute_content":[],"keywords":[]}
{"medgen_id":"C1837317","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012130\"}","{\"db\":\"OMIM\",\"id\":\"608810\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"280553\"}","{\"db\":\"Orphanet\",\"id\":\"399058\"}","{\"db\":\"OMIM\",\"id\":\"608810\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE\"}","{\"db\":\"OMIM\",\"id\":\"123590.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, 2\"}","{\"db\":\"OMIM\",\"id\":\"123590.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, 2\"}","{\"db\":\"OMIM\",\"id\":\"123590.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, 2\"}","{\"db\":\"OMIM\",\"id\":\"123590.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, 2\"}","{\"db\":\"OMIM\",\"id\":\"608810\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, 2\"}","{\"db\":\"OMIM\",\"id\":\"608810\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"123590.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"613869\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"608810\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, WITH OR WITHOUT CATARACT AND/OR CARDIOMYOPATHY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Alpha-B+crystallinopathy/7669\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"MYOPATHY%2C+MYOFIBRILLAR%2C+FATAL+INFANTILE+HYPERTONIC%2C+ALPHA-B+CRYSTALLIN-RELATED/8958\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608810\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Alpha-B crystallinopathy","symbol":"MFM2","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301672\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1499\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"type":"Disease","alternate_names":["MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE","MYOPATHY, MYOFIBRILLAR, 2","MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED","MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED","MYOPATHY, MYOFIBRILLAR, WITH OR WITHOUT CATARACT AND/OR CARDIOMYOPATHY"],"id":"156","attribute_content":[],"keywords":[]}
{"medgen_id":"C1837028","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012163\"}","{\"db\":\"OMIM\",\"id\":\"608971\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608971\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Severe+combined+immunodeficiency%2C+autosomal+recessive%2C+t+cell-negative%2C+b+cell-positive%2C+nk+cell-positive/9288\",\"ref_field\":\"name\"}"],"name":"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive","alternate_symbols":[],"type":"Disease","alternate_names":["SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE","Severe Combined Immune Deficiency, Autosomal Recessive, TCell -Negative, B Cell-Positive, NK Cell-Positive, IL7R-Related"],"id":"3721","attribute_content":[],"keywords":[]}
{"medgen_id":"C1836797","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012191\"}","{\"db\":\"OMIM\",\"id\":\"609060\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"137681\"}","{\"db\":\"OMIM\",\"id\":\"609060\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Combined+oxidative+phosphorylation+deficiency+1/8013\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609060\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Combined oxidative phosphorylation deficiency 1","symbol":"COXPD1","alternate_symbols":[],"type":"Disease","alternate_names":["HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE"],"id":"990","attribute_content":[],"keywords":[]}
{"medgen_id":"C5235139","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012476\"}","{\"db\":\"OMIM\",\"id\":\"610357\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"101010\"}","{\"db\":\"OMIM\",\"id\":\"601255.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"601255.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"601255.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"610357\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spastic+paraplegia+30%2C+autosomal+recessive/9318\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610357\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Spastic paraplegia 30, autosomal recessive","symbol":"SPG30","alternate_symbols":[],"type":"Disease","alternate_names":["SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT"],"id":"4412","attribute_content":[],"keywords":[]}
{"medgen_id":"C1864871","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012496\"}","{\"db\":\"OMIM\",\"id\":\"610443\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"96169\"}","{\"db\":\"Genetic Alliance\",\"id\":\"17q21.31+Microdeletion+Syndrome/9\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"17q21.31 microdeletion syndrome\"}","{\"db\":\"OMIM\",\"id\":\"610443\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHROMOSOME 17q21.31 DELETION SYNDROME\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK24676\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"KANSL1-Related Intellectual Disability Syndrome\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK24676\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"610443\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Koolen-de Vries syndrome","symbol":"KDVS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301783\",\"@Source\":\"PubMed\"},{\"$\":\"NBK24676\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Koolen-de Vries syndrome (KdVS) is characterized by developmental delay / intellectual disability, neonatal/childhood hypotonia, dysmorphisms, congenital malformations, and behavioral features. Psychomotor developmental delay is noted in all individuals from an early age. The majority of individuals with KdVS function in the mild-to-moderate range of intellectual disability. Other findings include speech and language delay (100%), epilepsy (~33%), congenital heart defects (25%-50%), renal and urologic anomalies (25%-50%), and cryptorchidism (71% of males). Behavior in most is described as friendly, amiable, and cooperative.","type":"Disease","alternate_names":["17q21.31 deletion syndrome","17q21.31 microdeletion syndrome","CHROMOSOME 17q21.31 DELETION SYNDROME","Chromosome 17q21.31 microdeletion syndrome","KANSL1-Related Intellectual Disability Syndrome","Monosomy 17q21.31"],"id":"904","attribute_content":[],"keywords":[]}
{"medgen_id":"C1853120","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012547\"}","{\"db\":\"OMIM\",\"id\":\"610733\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"648\"}","{\"db\":\"OMIM\",\"id\":\"163955\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NOONAN SYNDROME WITH PIGMENTED VILLONODULAR SYNOVITIS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Noonan+syndrome+4/5263\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1124\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"610733\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Noonan syndrome 4","symbol":"NS4","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301303\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1124\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AAP, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20876176\",\"@Source\":\"PubMed\"}}]}","alternate_symbols":[],"public_definition":"Noonan syndrome (NS) is characterized by characteristic facies, short stature, congenital heart defect, and developmental delay of variable degree. Other findings can include broad or webbed neck, unusual chest shape with superior pectus carinatum and inferior pectus excavatum, cryptorchidism, varied coagulation defects, lymphatic dysplasias, and ocular abnormalities. Although birth length is usually normal, final adult height approaches the lower limit of normal. Congenital heart disease occurs in 50%-80% of individuals. Pulmonary valve stenosis, often with dysplasia, is the most common heart defect and is found in 20%-50% of individuals. Hypertrophic cardiomyopathy, found in 20%-30% of individuals, may be present at birth or develop in infancy or childhood. Other structural defects include atrial and ventricular septal defects, branch pulmonary artery stenosis, and tetralogy of Fallot. Up to one fourth of affected individuals have mild intellectual disability, and language impairments in general are more common in NS than in the general population.","type":"Disease","alternate_names":["NL/MGCLS","NOONAN SYNDROME WITH PIGMENTED VILLONODULAR SYNOVITIS"],"id":"5654","attribute_content":[],"keywords":[]}
{"medgen_id":"C2677506","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012799\"}","{\"db\":\"OMIM\",\"id\":\"612098\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+hypertrophic+cardiomyopathy+11/8384\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612098\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Familial hypertrophic cardiomyopathy 11","symbol":"CMH11","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301725\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1768\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21267010\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","alternate_symbols":[],"type":"Disease","alternate_names":["ACTC1-Related Familial Hypertrophic Cardiomyopathy"],"id":"720","attribute_content":[],"keywords":[]}
{"medgen_id":"C2677491","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012804\"}","{\"db\":\"OMIM\",\"id\":\"612124\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+hypertrophic+cardiomyopathy+12/8385\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612124\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Familial hypertrophic cardiomyopathy 12","symbol":"CMH12","content":"{\"Citation\":{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21267010\",\"@Source\":\"PubMed\"}}}","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"678","attribute_content":[],"keywords":[]}
{"medgen_id":"C2676770","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012856\"}","{\"db\":\"OMIM\",\"id\":\"612292\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"166108\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Birk+Barel+Mental+Retardation+Dysmorphism+Syndrome/851\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Birk Barel mental retardation dysmorphism syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10358\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012856\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK425128\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612292\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Birk-Barel syndrome","symbol":"BIBARS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"28333430\",\"@Source\":\"PubMed\"},{\"$\":\"NBK425128\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"KCNK9 imprinting syndrome is characterized by congenital central hypotonia (manifest as decreased movement, lethargy, and weak cry), severe feeding difficulties (resulting from facial weakness and poor suck), delayed development/intellectual disability, and dysmorphic manifestations. Poor feeding can cause failure to thrive during infancy unless managed appropriately. Significant dysphagia of solid foods typically persists until puberty. Intellectual disability can be severe. To date 19 individuals with a molecularly confirmed diagnosis have been reported.","type":"Disease","alternate_names":["Birk Barel mental retardation dysmorphism syndrome","Mental retardation with hypotonia and facial dysmorphism"],"id":"1027","attribute_content":[],"gard_id":"10358","keywords":[]}
{"medgen_id":"C3496228","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012866\"}","{\"db\":\"OMIM\",\"id\":\"612319\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"171629\"}","{\"db\":\"OMIM\",\"id\":\"611026.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"611026.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"611026.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"611026.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"611026.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"611026.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"611026.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"611026.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"612319\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"612319\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FAHN\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leukodystrophy%2C+dysmyelinating%2C+and+spastic+paraparesis+with+or+without+dystonia/4201\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK56080\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612319\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Spastic paraplegia 35","symbol":"SPG35","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"21735565\",\"@Source\":\"PubMed\"},{\"$\":\"NBK56080\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23447832\",\"@Source\":\"PubMed\"},{\"$\":\"NBK121988\",\"@Source\":\"BookShelf\"}]}]}","alternate_symbols":["FAHN"],"public_definition":"Fatty acid hydroxylase-associated neurodegeneration (FAHN) is characterized early in the disease course by central nervous system involvement including corticospinal tract involvement (spasticity), mixed movement disorder (ataxia/dystonia), and eye findings (optic atrophy, oculomotor abnormalities), and later in the disease course by progressive intellectual impairment and seizures. With disease progression, dystonia and spasticity compromise the ability to ambulate, leading to wheelchair dependence. Life expectancy is variable. FAHN is considered to be a subtype of neurodegeneration with brain iron accumulation (NBIA).","type":"Disease","alternate_names":["Leukodystrophy, dysmyelinating, and spastic paraparesis with or without dystonia","SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE"],"id":"4413","attribute_content":[],"keywords":[]}
{"medgen_id":"C3151209","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013458\"}","{\"db\":\"OMIM\",\"id\":\"613845\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"363694\"}","{\"db\":\"OMIM\",\"id\":\"613845\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HUPRA SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"612804.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"612804.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"613845\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hyperuricemia%2C+pulmonary+hypertension%2C+renal+failure%2C+and+alkalosis/8608\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613845\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"613845\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis","symbol":"HUPRAS","alternate_symbols":[],"public_definition":"HUPRA syndrome is a severe autosomal recessive multisystem disorder characterized by onset in infancy of progressive renal failure leading to electrolyte imbalances, metabolic alkalosis, pulmonary hypertension, hypotonia, and delayed development. Affected individuals are born prematurely (summary by Belostotsky et al., 2011).","type":"Disease","alternate_names":["HUPRA SYNDROME","HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME"],"id":"16063","attribute_content":[],"keywords":[]}
{"medgen_id":"C3151267","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013477\"}","{\"db\":\"OMIM\",\"id\":\"613876\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+hypertrophic+cardiomyopathy+20/8392\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613876\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Familial hypertrophic cardiomyopathy 20","symbol":"CMH20","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301725\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1768\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"16037","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393830","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013656\"}","{\"db\":\"OMIM\",\"id\":\"614255\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mental+retardation%2C+autosomal+dominant+9/8832\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mental retardation, autosomal dominant 9\"}","{\"db\":\"OMIM\",\"id\":\"601255.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601255.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"614255\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NESCAV SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"614255\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEURODEGENERATION AND SPASTICITY WITH OR WITHOUT CEREBELLAR ATROPHY OR CORTICAL VISUAL IMPAIRMENT\"}","{\"db\":\"OMIM\",\"id\":\"614255\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRD9\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0013656\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614255\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Intellectual disability, autosomal dominant 9","symbol":"NESCAVS","alternate_symbols":["MRD9"],"type":"Disease","alternate_names":["Mental retardation, autosomal dominant 9","NESCAV SYNDROME","NEURODEGENERATION AND SPASTICITY WITH OR WITHOUT CEREBELLAR ATROPHY OR CORTICAL VISUAL IMPAIRMENT"],"id":"16569","attribute_content":[],"keywords":[]}
{"medgen_id":"C4518785","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0013881\"}","{\"db\":\"OMIM\",\"id\":\"614748\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"306504\"}","{\"db\":\"OMIM\",\"id\":\"614748\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614748\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital","symbol":"ILNEB","alternate_symbols":[],"public_definition":"Mutations in the integrin alpha-3 gene are associated with disrupted basement-membrane structures and compromised barrier functions in kidney, lung, and skin. Patients exhibit a multiorgan disorder that includes congenital interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa. The respiratory and renal features predominate, and lung involvement accounts for the lethal course of the disease (summary by Has et al., 2012).","type":"Disease","alternate_names":[],"id":"17328","attribute_content":[],"keywords":[]}
{"medgen_id":"C3554534","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014051\"}","{\"db\":\"OMIM\",\"id\":\"615119\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1561\"}","{\"db\":\"OMIM\",\"id\":\"603646.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"603646.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"603646.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"603646.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"615119\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6\"}","{\"db\":\"OMIM\",\"id\":\"615119\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CEMCOX2\"}","{\"db\":\"OMIM\",\"id\":\"615119\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2","symbol":"MC4DN6","alternate_symbols":["CEMCOX2"],"type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6"],"id":"17683","attribute_content":[],"keywords":[]}
{"medgen_id":"C4225400","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014206\"}","{\"db\":\"OMIM\",\"id\":\"615486\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615486\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY ALVEOLAR PROTEINOSIS, REUNION ISLAND\"}","{\"db\":\"OMIM\",\"id\":\"615486\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Interstitial lung and liver disease","symbol":"ILLD","alternate_symbols":[],"type":"Disease","alternate_names":["PULMONARY ALVEOLAR PROTEINOSIS, REUNION ISLAND"],"id":"18331","attribute_content":[],"keywords":[]}
{"medgen_id":"C4706563","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014219\"}","{\"db\":\"OMIM\",\"id\":\"615510\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"869\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"12404\",\"ref_field\":\"gard_id\"}","{\"db\":\"OMIM\",\"id\":\"615510\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Alacrima, achalasia, and mental retardation syndrome","symbol":"AAMR","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"18361","attribute_content":[],"gard_id":"12404","keywords":[]}
{"medgen_id":"C3809651","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014659\"}","{\"db\":\"OMIM\",\"id\":\"616483\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"440427\"}"],"name":"Infantile liver failure syndrome 2","symbol":"ILFS2","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"33970","attribute_content":[],"keywords":[]}
{"medgen_id":"C4225278","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014695\"}","{\"db\":\"OMIM\",\"id\":\"616568\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK563529\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"616568\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Glioma susceptibility 9","symbol":"GLM9","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"33119245\",\"@Source\":\"PubMed\"},{\"$\":\"NBK563529\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"POT1 tumor predisposition (POT1-TPD) is characterized by an increased lifetime risk for multiple cutaneous melanomas, chronic lymphocytic leukemia (CLL), angiosarcoma (particularly cardiac angiosarcomas), and gliomas. Additional cancers (e.g., colorectal cancer, thyroid cancer, breast angiosarcomas) have been reported in individuals with POT1-TPD but with very limited evidence. The age of onset for first primary cutaneous melanoma ranges from 15 to 80 years. The majority of POT1 associated cancers are diagnosed in adulthood.","type":"Disease","alternate_names":[],"id":"34308","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393908","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0014805\"}","{\"db\":\"OMIM\",\"id\":\"616863\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"500055\"}","{\"db\":\"OMIM\",\"id\":\"616863\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH, BEHAVIORAL ABNORMALITIES, AND DYSMORPHIC FACIES\"}","{\"db\":\"OMIM\",\"id\":\"616863\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Chromosome 16p13.2 deletion syndrome","symbol":"HAFOUS","alternate_symbols":[],"type":"Disease","alternate_names":["INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH, BEHAVIORAL ABNORMALITIES, AND DYSMORPHIC FACIES"],"id":"34882","attribute_content":[],"keywords":[]}
{"medgen_id":"C0265293","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0015942\"}","{\"db\":\"OMIM\",\"id\":\"PS305620\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"305620\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FMD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Frontometaphyseal+Dysplasia/2937\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS305620\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"62803002\",\"ref_field\":\"name\"}"],"name":"Frontometaphyseal dysplasia","alternate_symbols":["FMD"],"type":"Disease","alternate_names":[],"id":"43500","attribute_content":[],"keywords":[]}
{"medgen_id":"C0043207","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018105\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"wolfram-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK4144\",\"ref_field\":\"public_definition\"}"],"name":"Wolfram syndrome","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301607\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1434\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301750\",\"@Source\":\"PubMed\"},{\"$\":\"NBK4144\",\"@Source\":\"BookShelf\"}]}]}","alternate_symbols":[],"public_definition":"WFS1 Wolfram syndrome spectrum disorder (WFS1-WSSD) is a progressive neurodegenerative disorder characterized by onset of diabetes mellitus (DM) and optic atrophy (OA) before age 16 years, and typically associated with other endocrine abnormalities, sensorineural hearing loss, and progressive neurologic abnormalities (cerebellar ataxia, peripheral neuropathy, dementia, psychiatric illness, and urinary tract atony). Although DM is mostly insulin-dependent, overall the course is milder (with lower prevalence of microvascular disease) than that seen in isolated DM. OA typically results in significantly reduced visual acuity in the first decade. Sensorineural hearing impairment ranges from congenital deafness to milder, sometimes progressive, hearing impairment.","type":"Disease","alternate_names":[],"id":"18587","attribute_content":[],"keywords":[]}
{"medgen_id":"C3496337","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018170\"}","{\"db\":\"OMIM\",\"id\":\"600995\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"357502\"}","{\"db\":\"Orphanet\",\"id\":\"656\"}","{\"db\":\"OMIM\",\"id\":\"600995\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Nephrotic syndrome, type 2\"}","{\"db\":\"OMIM\",\"id\":\"600995\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SRN1\"}","{\"db\":\"NCI\",\"id\":\" C122796\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"357502\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600995\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Idiopathic nephrotic syndrome","symbol":"NPHS2","alternate_symbols":["SRN1"],"type":"Disease","alternate_names":["Nephrotic syndrome, steroid-resistant, autosomal recessive","Nephrotic syndrome, type 2"],"id":"5624","attribute_content":[],"keywords":[]}
{"medgen_id":"C0751038","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0019570\"}","{\"db\":\"OMIM\",\"id\":\"133540\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"191\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1342\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"133540\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Cockayne syndrome B","symbol":"CSB","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301516\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1342\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the \"classic\" or \"moderate\" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).","type":"Disease","alternate_names":["Cockayne Syndrome, Type II"],"id":"1524","attribute_content":[],"keywords":[]}
{"medgen_id":"C5235036","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0019696\"}","{\"db\":\"Orphanet\",\"id\":\"93437\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6\",\"ref_field\":\"gard_id\"}","{\"db\":\"Illumina Clinical Services Laboratory,Illumina\",\"id\":\"499998\",\"ref_field\":\"name\"}"],"name":"Acromesomelic Dysplasia","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"36376","attribute_content":[],"gard_id":"6","keywords":[]}
{"medgen_id":"C4509934","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0019779\"}","{\"db\":\"Orphanet\",\"id\":\"93975\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4672\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0019779\",\"ref_field\":\"name\"}"],"name":"Renier-Gabreels-Jasper syndrome","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"15331","attribute_content":[],"gard_id":"4672","keywords":[]}
{"medgen_id":"CN227858","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0020380\"}","{\"db\":\"Orphanet\",\"id\":\"99\"}","{\"db\":\"Illumina Clinical Services Laboratory,Illumina\",\"id\":\"115210\",\"ref_field\":\"name\"}"],"name":"Spinocerebellar Ataxia, Dominant","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"36440","attribute_content":[],"keywords":[]}
{"medgen_id":"C4551958","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0024553\"}","{\"db\":\"OMIM\",\"id\":\"600462\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2598\"}","{\"db\":\"OMIM\",\"id\":\"600462\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Myopathy, lactic acidosis, and sideroblastic anemia 1","symbol":"MLASA1","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"3211","attribute_content":[],"keywords":[]}
{"medgen_id":"C4012790","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0024557\"}","{\"db\":\"OMIM\",\"id\":\"604391\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"251347\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Early-Onset+Ataxia+with+Oculomotor+Apraxia+and+Hypoalbuminemia/2429\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604391\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Ataxia-telangiectasia-like disorder 1","symbol":"ATLD1","content":"{\"Citation\":{\"@Abbrev\":\"EFNS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20050888\",\"@Source\":\"PubMed\"}}}","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"461","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393302","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0026733\"}","{\"db\":\"OMIM\",\"id\":\"301039\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301039\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS, 2\"}","{\"db\":\"OMIM\",\"id\":\"300766.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300766.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300766.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300766.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300766.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301039\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301039\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE","symbol":"MRXSHD","alternate_symbols":[],"type":"Disease","alternate_names":["MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS, 2"],"id":"43770","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394296","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0030087\"}","{\"db\":\"OMIM\",\"id\":\"618856\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618856\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Permanent neonatal diabetes mellitus 2","symbol":"PNDM2","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52377","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394303","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0030088\"}","{\"db\":\"OMIM\",\"id\":\"618857\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618857\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Permanent neonatal diabetes mellitus 3","symbol":"PNDM3","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52378","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394307","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0030089\"}","{\"db\":\"OMIM\",\"id\":\"618858\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618858\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Permanent neonatal diabetes mellitus 4","symbol":"PNDM4","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52379","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394027","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032894\"}","{\"db\":\"OMIM\",\"id\":\"618741\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610971.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618741\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618741\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY","symbol":"NEDESBA","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43642","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394033","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032905\"}","{\"db\":\"OMIM\",\"id\":\"618768\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607915.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607915.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618768\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618768\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE","symbol":"SPG81","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43634","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394037","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032906\"}","{\"db\":\"OMIM\",\"id\":\"618770\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602679.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602679.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602679.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618770\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618770\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE","symbol":"SPG82","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43635","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394044","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032908\"}","{\"db\":\"OMIM\",\"id\":\"618774\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618774\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CRANIOFACIAL DEFECTS, DYSMORPHIC EARS, STRUCTURAL BRAIN ABNORMALITIES, EXPRESSIVE LANGUAGE DELAY, AND IMPAIRED INTELLECTUAL DEVELOPMENT\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032908\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618774\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"CEBALID syndrome","symbol":"CEBALID","alternate_symbols":[],"type":"Disease","alternate_names":["CRANIOFACIAL DEFECTS, DYSMORPHIC EARS, STRUCTURAL BRAIN ABNORMALITIES, EXPRESSIVE LANGUAGE DELAY, AND IMPAIRED INTELLECTUAL DEVELOPMENT","MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities"],"id":"43636","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394051","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032909\"}","{\"db\":\"OMIM\",\"id\":\"618775\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"191327.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"191327.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"191327.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"618775\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10\"}","{\"db\":\"OMIM\",\"id\":\"618775\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC3DN10\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032909\",\"ref_field\":\"name\"}"],"name":"Mitochondrial complex 3 deficiency, nuclear type 10","alternate_symbols":["MC3DN10"],"type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10"],"id":"43637","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394053","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032910\"}","{\"db\":\"OMIM\",\"id\":\"618776\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618461.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618461.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618461.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618461.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618776\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34\"}","{\"db\":\"OMIM\",\"id\":\"618776\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MC1DN34\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032910\",\"ref_field\":\"name\"}"],"name":"Mitochondrial complex 1 deficiency, nuclear type 34","alternate_symbols":["MC1DN34"],"type":"Disease","alternate_names":["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34"],"id":"43645","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394059","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032911\"}","{\"db\":\"OMIM\",\"id\":\"618778\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618778\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618778\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEAFNESS, AUTOSOMAL DOMINANT 75","symbol":"DFNA75","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43643","attribute_content":[],"keywords":[]}
{"medgen_id":"C5241442","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032912\"}","{\"db\":\"OMIM\",\"id\":\"618779\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601735.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601735.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601735.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601735.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601735.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618779\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618779\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"COFFIN-SIRIS SYNDROME 11","symbol":"CSS11","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43646","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394062","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032913\"}","{\"db\":\"OMIM\",\"id\":\"618780\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"136352.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136352.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136352.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136352.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"136352.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618780\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618780\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7","symbol":"CHTD7","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43640","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394063","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032914\"}","{\"db\":\"OMIM\",\"id\":\"618781\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618781\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 44, WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"618726.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618726.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618726.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618726.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618726.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618781\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618781\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"CILIARY DYSKINESIA, PRIMARY, 44","symbol":"CILD44","alternate_symbols":[],"type":"Disease","alternate_names":["CILIARY DYSKINESIA, PRIMARY, 44, WITHOUT SITUS INVERSUS"],"id":"43669","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394068","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032915\"}","{\"db\":\"OMIM\",\"id\":\"618782\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"114183.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114183.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618782\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618782\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"LONG QT SYNDROME 16","symbol":"LQT16","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43647","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394073","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032916\"}","{\"db\":\"OMIM\",\"id\":\"618786\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606245.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606245.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606245.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606245.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606245.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618786\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618786\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"IMAGAWA-MATSUMOTO SYNDROME","symbol":"IMMAS","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43653","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394080","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032917\"}","{\"db\":\"OMIM\",\"id\":\"618787\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602734.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602734.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602734.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602734.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618787\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618787\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEAFNESS, AUTOSOMAL DOMINANT 76","symbol":"DFNA76","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43654","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394081","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032918\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY IFANTILE, 84\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EIEE84\"}","{\"db\":\"OMIM\",\"id\":\"603370.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603370.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618792\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84","symbol":"DEE84","alternate_symbols":["EIEE84"],"type":"Disease","alternate_names":["EPILEPTIC ENCEPHALOPATHY, EARLY IFANTILE, 84"],"id":"43698","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394083","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032919\"}","{\"db\":\"OMIM\",\"id\":\"618793\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618793\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 62\"}","{\"db\":\"OMIM\",\"id\":\"602887.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602887.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618793\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618793\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"INTELLECTUAL DEVELOPMENTAL DISORDER 62","symbol":"MRD62","alternate_symbols":[],"type":"Disease","alternate_names":["MENTAL RETARDATION, AUTOSOMAL DOMINANT 62"],"id":"43719","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394091","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032921\"}","{\"db\":\"OMIM\",\"id\":\"618797\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608884.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608884.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608884.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608884.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608884.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618797\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618797\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION","symbol":"NEDHRIT","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43738","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394097","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032922\"}","{\"db\":\"OMIM\",\"id\":\"618798\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618798\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618798\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"BECK-FAHRNER SYNDROME","symbol":"BEFAHRS","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43740","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394101","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032923\"}","{\"db\":\"OMIM\",\"id\":\"618800\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618800\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618802.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28","symbol":"SCAR28","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43761","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394104","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032924\"}","{\"db\":\"OMIM\",\"id\":\"618801\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618801\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CILIARY DYSKINESIA, PRIMARY, 45, WITHOUT SITUS INVERSUS\"}","{\"db\":\"OMIM\",\"id\":\"610732.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610732.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610732.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610732.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618801\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618801\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"CILIARY DYSKINESIA, PRIMARY, 45","symbol":"CILD45","alternate_symbols":[],"type":"Disease","alternate_names":["CILIARY DYSKINESIA, PRIMARY, 45, WITHOUT SITUS INVERSUS"],"id":"43742","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394112","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032925\"}","{\"db\":\"OMIM\",\"id\":\"618803\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618803\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618803\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"RESPIRATORY PAPILLOMATOSIS, JUVENILE RECURRENT, CONGENITAL","symbol":"JRRP","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43762","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394118","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032926\"}","{\"db\":\"OMIM\",\"id\":\"618804\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615587.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615587.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615587.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615587.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615587.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615587.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615587.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618804\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618804\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"SANDESTIG-STEFANOVA SYNDROME","symbol":"SANDSTEF","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43743","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394125","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032927\"}","{\"db\":\"OMIM\",\"id\":\"618805\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615844.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615844.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618805\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618805\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME","symbol":"TKFCD","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43744","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394133","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032928\"}","{\"db\":\"OMIM\",\"id\":\"618806\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600838.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600838.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600838.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618806\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618806\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT","symbol":"TLIND","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43763","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394135","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032930\"}","{\"db\":\"OMIM\",\"id\":\"618808\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618808\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618808\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA","symbol":"IDPOGSA","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43787","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394137","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032931\"}","{\"db\":\"OMIM\",\"id\":\"618810\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618810\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PHRINL SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"612316.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612316.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612316.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618810\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618810\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"PONTOCEREBELLAR HYPOPLASIA, HYPOTONIA, AND RESPIRATORY INSUFFICIENCY SYNDROME, NEONATAL LETHAL","symbol":"PHRINL","alternate_symbols":[],"type":"Disease","alternate_names":["PHRINL SYNDROME"],"id":"43781","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394140","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032932\"}","{\"db\":\"OMIM\",\"id\":\"618811\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618811\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618811\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"MITOCHONDRIAL DNA DEPLETION SYNDROME 18","symbol":"MTDPS18","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43777","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394158","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032934\"}","{\"db\":\"OMIM\",\"id\":\"618820\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602021.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602021.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602021.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618820\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618820\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME","symbol":"GUBS","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43778","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394173","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032935\"}","{\"db\":\"OMIM\",\"id\":\"618821\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"614150.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614150.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618821\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618821\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"RHIZOMELIC LIMB SHORTENING WITH DYSMORPHIC FEATURES","symbol":"RLSDF","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43779","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394189","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032936\"}","{\"db\":\"OMIM\",\"id\":\"618822\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618822\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618822\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"MYOPATHY, CONGENITAL, WITH RESPIRATORY INSUFFICIENCY AND BONE FRACTURES","symbol":"MYORIBF","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43785","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394193","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032937\"}","{\"db\":\"OMIM\",\"id\":\"618823\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618823\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618823\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"MYOPATHY, CONGENITAL PROXIMAL, WITH MINICORE LESIONS","symbol":"MYOPMIL","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43786","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394199","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032938\"}","{\"db\":\"OMIM\",\"id\":\"618824\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606870.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606870.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618824\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618824\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE","symbol":"IBGC8","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43793","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394205","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032939\"}","{\"db\":\"OMIM\",\"id\":\"618825\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618825\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY\"}","{\"db\":\"OMIM\",\"id\":\"601893.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601893.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601893.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601893.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618825\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618825\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY","symbol":"MRD63","alternate_symbols":[],"type":"Disease","alternate_names":["MENTAL RETARDATION, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY"],"id":"43804","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394208","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032940\"}","{\"db\":\"OMIM\",\"id\":\"618826\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608581.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608581.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608581.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608581.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608581.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618826\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618826\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"RETINITIS PIGMENTOSA 88","symbol":"RP88","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43788","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394215","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032941\"}","{\"db\":\"OMIM\",\"id\":\"618827\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606027.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606027.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606027.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606027.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618827\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618827\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"MYOPIA 27","symbol":"MYP27","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43794","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394218","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032942\"}","{\"db\":\"OMIM\",\"id\":\"618828\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602650.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"602650.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"618828\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"618828\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NEDMIDF\"}","{\"db\":\"OMIM\",\"id\":\"618828\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NSDVS1\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032942\",\"ref_field\":\"name\"}"],"name":"Neurodevelopmental disorder with microcephaly and dysmorphic facies","alternate_symbols":["NEDMIDF","NSDVS1"],"type":"Disease","alternate_names":["NABAIS SA-DE VRIES SYNDROME, TYPE 1"],"id":"43806","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394221","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0032943\"}","{\"db\":\"OMIM\",\"id\":\"618829\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602650.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602650.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602650.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"602650.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"618829\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NABAIS SA-DE VRIES SYNDROME, TYPE 2\"}","{\"db\":\"OMIM\",\"id\":\"618829\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NEDMACE\"}","{\"db\":\"OMIM\",\"id\":\"618829\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NSDVS2\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0032943\",\"ref_field\":\"name\"}"],"name":"Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies","alternate_symbols":["NEDMACE","NSDVS2"],"type":"Disease","alternate_names":["NABAIS SA-DE VRIES SYNDROME, TYPE 2"],"id":"43807","attribute_content":[],"keywords":[]}
{"medgen_id":"C4540411","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0033366\"}","{\"db\":\"OMIM\",\"id\":\"617771\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617771\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57\"}","{\"db\":\"OMIM\",\"id\":\"617771\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EIEE57\"}","{\"db\":\"OMIM\",\"id\":\"610044.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610044.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610044.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610044.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610044.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610044.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617771\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617771\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57","symbol":"DEE57","alternate_symbols":["EIEE57"],"type":"Disease","alternate_names":["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57"],"id":"38351","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394277","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0100058\"}","{\"db\":\"OMIM\",\"id\":\"618850\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618850\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRANCHED-CHAIN AMINOTRANSFERASE DEFICIENCY\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0100058\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618850\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Hypervalinemia and hyperleucine-isoleucinemia","symbol":"HVLI","alternate_symbols":[],"type":"Disease","alternate_names":["BRANCHED-CHAIN AMINOTRANSFERASE DEFICIENCY"],"id":"50230","attribute_content":[],"keywords":[]}
{"medgen_id":"C2931187","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0100151\"}","{\"db\":\"OMIM\",\"id\":\"219800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"213\"}","{\"db\":\"Orphanet\",\"id\":\"411629\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0021725\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abderhalden-Kaufmann-Lignac syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10074\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneTests\",\"id\":\"54105\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Nephropathic+cystinosis/5143\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1400\",\"ref_field\":\"public_definition\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529128\",\"ref_field\":\"symbol\"}","{\"db\":\"OMIM\",\"id\":\"219800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Nephropathic cystinosis","symbol":"CTNS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301574\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1400\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.","type":"Disease","alternate_names":["Abderhalden Lignac Kaufmann disease","Abderhalden-Kaufmann-Lignac syndrome","Cystine diathesis","Cystine disease","Cystine storage disease","Cystinoses","Cystinosin, defect of","Lysosomal cystine transport protein, defect of"],"id":"15909","attribute_content":[],"gard_id":"10074","keywords":[]}
{"medgen_id":"CN257533","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0100224\"}","{\"db\":\"OMIM\",\"id\":\"252010\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"252010\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL NADH DEHYDROGENASE COMPONENT OF COMPLEX I, DEFICIENCY OF\"}","{\"db\":\"OMIM\",\"id\":\"252010\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NADH-COENZYME Q REDUCTASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"252010\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Mitochondrial complex I deficiency, nuclear type 1","symbol":"MC1DN1","alternate_symbols":[],"type":"Disease","alternate_names":["MITOCHONDRIAL NADH DEHYDROGENASE COMPONENT OF COMPLEX I, DEFICIENCY OF","NADH-COENZYME Q REDUCTASE DEFICIENCY"],"id":"40916","attribute_content":[],"keywords":[]}
{"medgen_id":"C5241444","xrefs":["{\"db\":\"OMIM\",\"id\":\"146200\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"146200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Hypoparathyroidism, familial isolated 1","symbol":"FIH1","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53867","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393299","xrefs":["{\"db\":\"OMIM\",\"id\":\"300958\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"457260\"}","{\"db\":\"OMIM\",\"id\":\"300160.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300160.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300958\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300958\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRX102\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK561282\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300958\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Mental retardation, X-linked 102","symbol":"MRXSSB","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32852922\",\"@Source\":\"PubMed\"},{\"$\":\"NBK561282\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["MRX102"],"public_definition":"DDX3X-related neurodevelopmental disorder (DDX3X-NDD) typically occurs in females and very rarely in males. All affected individuals reported to date have developmental delay / intellectual disability (ID) ranging from mild to severe; about 50% of affected girls remain nonverbal after age five years. Hypotonia, a common finding, can be associated with feeding difficulty in infancy. Behavioral issues can include autism spectrum disorder, attention-deficit/hyperactivity disorder and hyperactivity, self-injurious behavior, poor impulse control, and aggression. Other findings can include seizures, movement disorders (dyskinesia, spasticity, abnormal gait), vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis. Neuroblastoma has been observed in three individuals.","type":"Disease","alternate_names":["INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE"],"id":"34131","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393303","xrefs":["{\"db\":\"OMIM\",\"id\":\"301041\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301041\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Wieacker-Wolff syndrome, female-restricted","symbol":"WRWFFR","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43821","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393308","xrefs":["{\"db\":\"OMIM\",\"id\":\"301043\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"300826.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300826.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301043\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301043\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"HOLOPROSENCEPHALY 13, X-LINKED","symbol":"HPE13","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43827","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393312","xrefs":["{\"db\":\"OMIM\",\"id\":\"301044\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301044\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 85, WITH OR WITHOUT MIDLINE BRAIN DEFECTS\"}","{\"db\":\"OMIM\",\"id\":\"301044\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EIEE85\"}","{\"db\":\"OMIM\",\"id\":\"300040.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301044\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301044\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS","symbol":"DEE85","alternate_symbols":["EIEE85"],"type":"Disease","alternate_names":["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 85, WITH OR WITHOUT MIDLINE BRAIN DEFECTS"],"id":"43829","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393313","xrefs":["{\"db\":\"OMIM\",\"id\":\"301045\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301045\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CDG IIr\"}","{\"db\":\"OMIM\",\"id\":\"301045\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDGIIR\"}","{\"db\":\"OMIM\",\"id\":\"300556.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300556.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301045\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301045\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr","symbol":"CDG2R","alternate_symbols":["CDGIIR"],"type":"Disease","alternate_names":["CDG IIr"],"id":"52345","attribute_content":[],"keywords":[]}
{"medgen_id":"C5393318","xrefs":["{\"db\":\"OMIM\",\"id\":\"301052\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"301052\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COUMARIN SENSITIVITY, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300746.0102\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300746.0103\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"301052\",\"type\":\"MIM\",\"ref_field\":\"name\"}"],"name":"WARFARIN SENSITIVITY, X-LINKED","alternate_symbols":[],"type":"Disease","alternate_names":["COUMARIN SENSITIVITY, X-LINKED"],"id":"53830","attribute_content":[],"keywords":[]}
{"medgen_id":"C2751053","xrefs":["{\"db\":\"OMIM\",\"id\":\"613148\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"238569\"}","{\"db\":\"OMIM\",\"id\":\"613148\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INFLAMMATORY BOWEL DISEASE, EARLY-ONSET, AUTOSOMAL RECESSIVE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Inflammatory+bowel+disease+28%2C+autosomal+recessive/8671\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613148\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Inflammatory bowel disease 28, autosomal recessive","symbol":"IBD28","alternate_symbols":[],"type":"Disease","alternate_names":["INFLAMMATORY BOWEL DISEASE, EARLY-ONSET, AUTOSOMAL RECESSIVE","Inflammatory bowel disease 28"],"id":"6776","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394226","xrefs":["{\"db\":\"OMIM\",\"id\":\"618830\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600568.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600568.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600568.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618830\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618830\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"AUTISM, SUSCEPTIBILITY TO, 20","symbol":"AUTS20","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52442","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394228","xrefs":["{\"db\":\"OMIM\",\"id\":\"618832\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618832\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618832\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY","symbol":"EPEDD","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43820","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394232","xrefs":["{\"db\":\"OMIM\",\"id\":\"618835\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617209.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617209.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617209.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617209.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617209.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617209.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618835\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618835\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40","symbol":"COXPD40","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43822","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394236","xrefs":["{\"db\":\"OMIM\",\"id\":\"618838\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618838\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618838\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41","symbol":"COXPD41","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43823","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394237","xrefs":["{\"db\":\"OMIM\",\"id\":\"618839\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617210.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618839\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618839\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42","symbol":"COXPD42","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43824","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394241","xrefs":["{\"db\":\"OMIM\",\"id\":\"618840\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600909.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600909.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600909.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600909.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600909.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600909.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600909.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618840\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618840\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"ALOPECIA-MENTAL RETARDATION SYNDROME 4","symbol":"APMR4","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43816","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394246","xrefs":["{\"db\":\"OMIM\",\"id\":\"618841\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"616506.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616506.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616506.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618841\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618841\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA","symbol":"HH25","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"43817","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394250","xrefs":["{\"db\":\"OMIM\",\"id\":\"618845\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618845\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONGENITAL NAD DEFICIENCY DISORDER 3\"}","{\"db\":\"OMIM\",\"id\":\"608285.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608285.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608285.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608285.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618845\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618845\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3","symbol":"VCRL3","alternate_symbols":[],"type":"Disease","alternate_names":["CONGENITAL NAD DEFICIENCY DISORDER 3"],"id":"43825","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394263","xrefs":["{\"db\":\"OMIM\",\"id\":\"618846\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618846\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTELLECTUAL DEVELOPMENTAL DISORDER WITH DISTINCTIVE FACIAL DYSMORPHISM\"}","{\"db\":\"OMIM\",\"id\":\"618846\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IDDFD\"}","{\"db\":\"OMIM\",\"id\":\"609373.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609373.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609373.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609373.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"609373.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618846\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618846\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DIETS-JONGMANS SYNDROME","symbol":"DIJOS","alternate_symbols":["IDDFD"],"type":"Disease","alternate_names":["INTELLECTUAL DEVELOPMENTAL DISORDER WITH DISTINCTIVE FACIAL DYSMORPHISM"],"id":"43828","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394265","xrefs":["{\"db\":\"OMIM\",\"id\":\"618847\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618847\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618847\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"IMMUNODEFICIENCY 66","symbol":"IMD66","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52341","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394268","xrefs":["{\"db\":\"OMIM\",\"id\":\"618848\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"605824.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605824.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605824.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618848\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618848\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 26","symbol":"LGMDR26","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52343","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394274","xrefs":["{\"db\":\"OMIM\",\"id\":\"618849\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618849\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618849\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"BONE MARROW FAILURE SYNDROME 6","symbol":"BMFS6","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52346","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394284","xrefs":["{\"db\":\"OMIM\",\"id\":\"618851\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618851\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618851\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 43","symbol":"COXPD43","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52348","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394286","xrefs":["{\"db\":\"OMIM\",\"id\":\"618852\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618852\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CLEAVAGE-RESISTANT RIPK1-INDUCED AUTOINFLAMMATORY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"618852\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CRIA SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"603453.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603453.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603453.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603453.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618852\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618852\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"AUTOINFLAMMATION WITH EPISODIC FEVER AND LYMPHADENOPATHY","symbol":"AIEFL","alternate_symbols":[],"type":"Disease","alternate_names":["CLEAVAGE-RESISTANT RIPK1-INDUCED AUTOINFLAMMATORY SYNDROME","CRIA SYNDROME"],"id":"52359","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394289","xrefs":["{\"db\":\"OMIM\",\"id\":\"618853\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617089.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617089.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618853\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618853\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"ANAUXETIC DYSPLASIA 3","symbol":"ANXD3","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52347","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394293","xrefs":["{\"db\":\"OMIM\",\"id\":\"618855\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"612322.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612322.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612322.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612322.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612322.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612322.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618855\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618855\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44","symbol":"COXPD44","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52376","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394311","xrefs":["{\"db\":\"OMIM\",\"id\":\"618859\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618859\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618859\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISTIC FEATURES AND/OR STRUCTURAL BRAIN ABNORMALITIES","symbol":"NEDASB","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52380","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394312","xrefs":["{\"db\":\"OMIM\",\"id\":\"618862\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"601218.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601218.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601218.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601218.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601218.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618862\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618862\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES","symbol":"NEDHYMS","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52381","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394315","xrefs":["{\"db\":\"OMIM\",\"id\":\"618863\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"616618.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616618.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618863\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618863\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"RETINAL DYSTROPHY WITH LEUKODYSTROPHY","symbol":"RDLKD","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52360","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394329","xrefs":["{\"db\":\"OMIM\",\"id\":\"618866\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618866\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618866\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"TREMOR, HEREDITARY ESSENTIAL, 6","symbol":"ETM6","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52386","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394335","xrefs":["{\"db\":\"OMIM\",\"id\":\"618868\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"606105.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606105.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606105.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618868\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618868\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE","symbol":"CONATOC","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52387","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394341","xrefs":["{\"db\":\"OMIM\",\"id\":\"618870\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"616615.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616615.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616615.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616615.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"616615.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618870\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618870\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"SKELETAL DYSPLASIA, MILD, WITH JOINT LAXITY AND ADVANCED BONE AGE","symbol":"SDJLABA","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52385","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394350","xrefs":["{\"db\":\"OMIM\",\"id\":\"618872\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"611318.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611318.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611318.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618872\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618872\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NIZON-ISIDOR SYNDROME","symbol":"NIZIDS","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52388","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394354","xrefs":["{\"db\":\"OMIM\",\"id\":\"618873\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618865.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618865.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618865.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618865.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618865.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618873\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618873\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"LISSENCEPHALY 10","symbol":"LIS10","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52427","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394359","xrefs":["{\"db\":\"OMIM\",\"id\":\"618875\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615322.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615322.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615322.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615322.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615322.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615322.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618875\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618875\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"SEIZURES, EARLY-ONSET, WITH NEURODEGENERATION AND BRAIN CALCIFICATIONS","symbol":"SENEBAC","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52447","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394362","xrefs":["{\"db\":\"OMIM\",\"id\":\"618876\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608873.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608873.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"608873.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618876\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618876\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"EPILEPSY, PROGRESSIVE MYOCLONIC, 11","symbol":"EPM11","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52436","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394367","xrefs":["{\"db\":\"OMIM\",\"id\":\"618877\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618877\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUDEN SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"176871.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"176871.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"176871.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"176871.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"176871.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618877\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618877\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME","symbol":"LEUDEN","alternate_symbols":[],"type":"Disease","alternate_names":["LEUDEN SYNDROME"],"id":"52443","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394371","xrefs":["{\"db\":\"OMIM\",\"id\":\"618878\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618878\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEMSPAD SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"618878\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618878\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME","symbol":"LEMSPAD","alternate_symbols":[],"type":"Disease","alternate_names":["LEMSPAD SYNDROME"],"id":"52444","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394372","xrefs":["{\"db\":\"OMIM\",\"id\":\"618879\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618879\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 22\"}","{\"db\":\"OMIM\",\"id\":\"618879\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GPIBD22\"}","{\"db\":\"OMIM\",\"id\":\"605087.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605087.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618879\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618879\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES","symbol":"NEDHCAS","alternate_symbols":["GPIBD22"],"type":"Disease","alternate_names":["GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 22"],"id":"52448","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394374","xrefs":["{\"db\":\"OMIM\",\"id\":\"618880\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618880\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618880\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"GLAUCOMA, PRIMARY CLOSED-ANGLE","symbol":"GLCC","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52432","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394377","xrefs":["{\"db\":\"OMIM\",\"id\":\"618881\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618881\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GALACTOSE MUTAROTASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"137030.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137030.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137030.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137030.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"137030.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618881\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618881\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"GALACTOSEMIA IV","symbol":"GALAC4","alternate_symbols":[],"type":"Disease","alternate_names":["GALACTOSE MUTAROTASE DEFICIENCY"],"id":"52445","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394383","xrefs":["{\"db\":\"OMIM\",\"id\":\"618883\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603716.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603716.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603716.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603716.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618883\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618883\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2","symbol":"FIH2","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52446","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394384","xrefs":["{\"db\":\"OMIM\",\"id\":\"618884\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"602997.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602997.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602997.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602997.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618884\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618884\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"PROTEINURIA, CHRONIC BENIGN","symbol":"PROCHOB","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52450","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394387","xrefs":["{\"db\":\"OMIM\",\"id\":\"618885\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618885\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CDG IIt\"}","{\"db\":\"OMIM\",\"id\":\"618885\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDGIIt\"}","{\"db\":\"OMIM\",\"id\":\"602274.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602274.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602274.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602274.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602274.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618885\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618885\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt","symbol":"CDG2T","alternate_symbols":["CDGIIt"],"type":"Disease","alternate_names":["CDG IIt"],"id":"52484","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394391","xrefs":["{\"db\":\"OMIM\",\"id\":\"618886\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600556.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600556.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618886\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618886\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"PSEUDO-TORCH SYNDROME 3","symbol":"PTORCH3","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52512","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394404","xrefs":["{\"db\":\"OMIM\",\"id\":\"618889\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618889\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, LIBERFARB TYPE\"}","{\"db\":\"OMIM\",\"id\":\"618889\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SEMDLIBF\"}","{\"db\":\"OMIM\",\"id\":\"618889\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Liberfarb syndrome","symbol":"LIBF","alternate_symbols":["SEMDLIBF"],"type":"Disease","alternate_names":["SPONDYLOEPIMETAPHYSEAL DYSPLASIA, LIBERFARB TYPE"],"id":"52485","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394423","xrefs":["{\"db\":\"OMIM\",\"id\":\"618890\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618890\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618890\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY","symbol":"NEDBASS","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52515","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394425","xrefs":["{\"db\":\"OMIM\",\"id\":\"618891\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"123859.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"123859.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"123859.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"123859.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"123859.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618891\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618891\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME","symbol":"MDBH","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52486","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394441","xrefs":["{\"db\":\"OMIM\",\"id\":\"618901\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"107773.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"107773.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618901\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618901\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"46,XX SEX REVERSAL 5","symbol":"SRXX5","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"52519","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394447","xrefs":["{\"db\":\"OMIM\",\"id\":\"618906\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618906\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618906\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY, WITH OR WITHOUT SEIZURES","symbol":"IDDALDS","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53481","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394450","xrefs":["{\"db\":\"OMIM\",\"id\":\"618907\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603026.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603026.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618907\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1324\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618907\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"SILVER-RUSSELL SYNDROME 4","symbol":"SRS4","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301499\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1324\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Silver-Russell Syndrome (SRS) is typically characterized by asymmetric gestational growth restriction resulting in affected individuals being born small for gestational age, with relative macrocephaly at birth (head circumference =1.5 SD above birth weight and/or length), prominent forehead usually with frontal bossing, and frequently body asymmetry. This is followed by postnatal growth failure, and in some cases progressive limb length discrepancy and feeding difficulties. Additional clinical features include triangular facies, fifth-finger clinodactyly, and micrognathia with narrow chin. Except for the limb length asymmetry, the growth failure is proportionate and head growth normal. The average adult height in untreated individuals is ~3.1±1.4 SD below the mean. The Netchine-Harbison Clinical Scoring System (NH-CSS) is a sensitive diagnostic scoring system. Clinical diagnosis can be established in an individual who meets at least four of the NH-CSS clinical criteria – prominent forehead/frontal bossing and relative macrocephaly at birth plus two additional findings – and in whom other disorders have been ruled out.","type":"Disease","alternate_names":[],"id":"53372","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394456","xrefs":["{\"db\":\"OMIM\",\"id\":\"618908\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1324\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618908\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Silver-Russell syndrome 5","symbol":"SRS5","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301499\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1324\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Silver-Russell Syndrome (SRS) is typically characterized by asymmetric gestational growth restriction resulting in affected individuals being born small for gestational age, with relative macrocephaly at birth (head circumference =1.5 SD above birth weight and/or length), prominent forehead usually with frontal bossing, and frequently body asymmetry. This is followed by postnatal growth failure, and in some cases progressive limb length discrepancy and feeding difficulties. Additional clinical features include triangular facies, fifth-finger clinodactyly, and micrognathia with narrow chin. Except for the limb length asymmetry, the growth failure is proportionate and head growth normal. The average adult height in untreated individuals is ~3.1±1.4 SD below the mean. The Netchine-Harbison Clinical Scoring System (NH-CSS) is a sensitive diagnostic scoring system. Clinical diagnosis can be established in an individual who meets at least four of the NH-CSS clinical criteria – prominent forehead/frontal bossing and relative macrocephaly at birth plus two additional findings – and in whom other disorders have been ruled out.","type":"Disease","alternate_names":[],"id":"53373","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394462","xrefs":["{\"db\":\"OMIM\",\"id\":\"618910\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618910\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 86\"}","{\"db\":\"OMIM\",\"id\":\"618910\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EIEE86\"}","{\"db\":\"OMIM\",\"id\":\"618910\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618910\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86","symbol":"DEE86","alternate_symbols":["EIEE86"],"type":"Disease","alternate_names":["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 86"],"id":"53475","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394466","xrefs":["{\"db\":\"OMIM\",\"id\":\"618912\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618912\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SORBITOL DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"182500.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"182500.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618912\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618912\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"SORBITOL DEHYDROGENASE DEFICIENCY WITH PERIPHERAL NEUROPATHY","symbol":"SORDD","alternate_symbols":[],"type":"Disease","alternate_names":["SORBITOL DEHYDROGENASE DEFICIENCY"],"id":"53482","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394473","xrefs":["{\"db\":\"OMIM\",\"id\":\"618913\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618913\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FANCONI RENOTUBULAR SYNDROME, ACADIAN VARIANT\"}","{\"db\":\"OMIM\",\"id\":\"612392.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618913\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618913\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"FANCONI RENOTUBULAR SYNDROME 5","symbol":"FRTS5","alternate_symbols":[],"type":"Disease","alternate_names":["FANCONI RENOTUBULAR SYNDROME, ACADIAN VARIANT"],"id":"53425","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394477","xrefs":["{\"db\":\"OMIM\",\"id\":\"618914\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618914\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Neurodevelopmental, jaw, eye, and digital syndrome","symbol":"NEDJED","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53426","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394499","xrefs":["{\"db\":\"OMIM\",\"id\":\"618915\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618915\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618915\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEAFNESS, AUTOSOMAL DOMINANT 77","symbol":"DFNA77","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53483","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394501","xrefs":["{\"db\":\"OMIM\",\"id\":\"618916\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618916\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 87\"}","{\"db\":\"OMIM\",\"id\":\"618916\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EIEE87\"}","{\"db\":\"OMIM\",\"id\":\"614720.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614720.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618916\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618916\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87","symbol":"DEE87","alternate_symbols":["EIEE87"],"type":"Disease","alternate_names":["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 87"],"id":"53547","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394502","xrefs":["{\"db\":\"OMIM\",\"id\":\"618917\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"138247.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138247.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138247.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138247.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138247.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"138247.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618917\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618917\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES","symbol":"NEDLIB","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53548","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394503","xrefs":["{\"db\":\"OMIM\",\"id\":\"618918\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"157129.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"157129.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"157129.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"157129.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"157129.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"157129.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"157129.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618918\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618918\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"PERIVENTRICULAR NODULAR HETEROTOPIA 9","symbol":"PVNH9","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53558","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394505","xrefs":["{\"db\":\"OMIM\",\"id\":\"618920\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618920\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 14\"}","{\"db\":\"OMIM\",\"id\":\"618920\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ARVC14\"}","{\"db\":\"OMIM\",\"id\":\"114020.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114020.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618920\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618920\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 14","symbol":"ARVD14","alternate_symbols":["ARVC14"],"type":"Disease","alternate_names":["ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 14"],"id":"53543","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394517","xrefs":["{\"db\":\"OMIM\",\"id\":\"618922\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604101.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604101.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604101.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604101.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604101.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604101.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604101.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618922\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618922\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES","symbol":"NEDSHBA","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53622","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394520","xrefs":["{\"db\":\"OMIM\",\"id\":\"618924\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618924\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Episodic ataxia type 9","symbol":"EA9","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"33247","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394523","xrefs":["{\"db\":\"OMIM\",\"id\":\"618929\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"114020.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114020.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114020.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114020.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114020.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114020.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"114020.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618929\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618929\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"AGENESIS OF CORPUS CALLOSUM, CARDIAC, OCULAR, AND GENITAL SYNDROME","symbol":"ACOGS","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53549","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394542","xrefs":["{\"db\":\"OMIM\",\"id\":\"618935\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618935\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GRANULOMATOUS DISEASE, CHRONIC, DUE TO CYBC1 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"618935\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Autosomal recessive chronic granulomatous disease 5","symbol":"CGD5","alternate_symbols":[],"type":"Disease","alternate_names":["GRANULOMATOUS DISEASE, CHRONIC, DUE TO CYBC1 DEFICIENCY"],"id":"53609","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394546","xrefs":["{\"db\":\"OMIM\",\"id\":\"618939\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1532\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618939\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Treacher Collins syndrome 4","symbol":"TCS4","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301704\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1532\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.","type":"Disease","alternate_names":[],"id":"53610","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394548","xrefs":["{\"db\":\"OMIM\",\"id\":\"618940\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"605072.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618940\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618940\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"OCULOPHARYNGODISTAL MYOPATHY 2","symbol":"OPDM2","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53623","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394550","xrefs":["{\"db\":\"OMIM\",\"id\":\"618944\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"147880.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"147880.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618944\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618944\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"HYPER-IgE RECURRENT INFECTION SYNDROME 5, AUTOSOMAL RECESSIVE","symbol":"HIES5","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53782","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394551","xrefs":["{\"db\":\"OMIM\",\"id\":\"618948\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610766.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610766.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618948\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618948\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"HETEROTAXY, VISCERAL, 9, AUTOSOMAL, WITH MALE INFERTILITY","symbol":"HTX9","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53827","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394552","xrefs":["{\"db\":\"OMIM\",\"id\":\"618955\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"603754.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603754.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618955\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618955\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"RETINITIS PIGMENTOSA 89","symbol":"RP89","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53767","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394553","xrefs":["{\"db\":\"OMIM\",\"id\":\"618959\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618959\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 88\"}","{\"db\":\"OMIM\",\"id\":\"618959\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EIEE88\"}","{\"db\":\"OMIM\",\"id\":\"618959\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618959\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88","symbol":"DEE88","alternate_symbols":["EIEE88"],"type":"Disease","alternate_names":["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 88"],"id":"53783","attribute_content":[],"keywords":[]}
{"medgen_id":"C5394554","xrefs":["{\"db\":\"OMIM\",\"id\":\"618960\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"609751.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618960\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618960\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"MITCHELL SYNDROME","symbol":"MITCH","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"53828","attribute_content":[],"keywords":[]}
{"medgen_id":"C3536714","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000110\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000116\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004721\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008660\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0019638\"}","{\"db\":\"OMIM\",\"id\":\"267430\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000110\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dysplastic kidneys\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000110\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal adysplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008660\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal tubular dysgenesis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008660\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renotubular dysgenesis\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Renal+dysplasia/9216\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000110\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"204949001\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"267430\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Renal dysplasia","symbol":"RTD","alternate_symbols":[],"type":"Disease","alternate_names":["Dysplastic kidneys","Primitive renal tubule syndrome","Renal adysplasia","Renal tubular dysgenesis","Renotubular dysgenesis"],"id":"21426","attribute_content":[],"keywords":[]}
{"medgen_id":"C0035353","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002053\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002954\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Receding chin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Receding lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Receding mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retrogenia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retrognathia of lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Weak chin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Weak jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000278\",\"ref_field\":\"name\"}"],"name":"Retrognathia","alternate_symbols":[],"type":"Finding","alternate_names":["Receding chin","Receding lower jaw","Receding mandible","Retrogenia","Retrognathia of lower jaw","Weak chin","Weak jaw"],"id":"17083","attribute_content":[],"keywords":[]}
{"medgen_id":"C4760994","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000629\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000629\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fullness around the eyes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000629\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Periorbital puffiness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000629\",\"ref_field\":\"name\"}"],"name":"Periorbital fullness","alternate_symbols":[],"type":"Finding","alternate_names":["Fullness around the eyes","Periorbital puffiness"],"id":"21802","attribute_content":[],"keywords":[]}
{"medgen_id":"C0005747","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000643\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007907\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011728\"}","{\"db\":\"OMIM\",\"id\":\"606798\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Eyelid spasm\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Eyelid twitching\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Involuntary closure of eyelid\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spontaneous closure of eyelid\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5909\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Blepharospasm/876\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000643\",\"ref_field\":\"name\"}"],"name":"Blepharospasm","symbol":"BEB","alternate_symbols":[],"type":"Finding","alternate_names":["Benign Essential Blepharospasm","Eyelid spasm","Eyelid twitching","Involuntary closure of eyelid","Spontaneous closure of eyelid"],"id":"21815","attribute_content":[],"gard_id":"5909","keywords":[]}
{"medgen_id":"C0344559","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000659\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011414\"}","{\"db\":\"OMIM\",\"id\":\"604229\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"708\"}","{\"db\":\"OMIM\",\"id\":\"604229\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANTERIOR SEGMENT DYSGENESIS 5\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7377\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Irido-corneo-trabecular+dysgenesis/8682\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"204153003\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604229\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Irido-corneo-trabecular dysgenesis","symbol":"ASGD5","alternate_symbols":[],"type":"Disease","alternate_names":["ANTERIOR SEGMENT DYSGENESIS 5"],"id":"3486","attribute_content":[],"gard_id":"7377","keywords":[]}
{"medgen_id":"C2051831","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000767\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006613\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006617\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008213\"}","{\"db\":\"OMIM\",\"id\":\"169300\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000767\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Funnel chest\"}"],"name":"Pectus excavatum","content":"{\"Citation\":{\"@Abbrev\":\"ACMG, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"22237449\",\"@Source\":\"PubMed\"}}}","alternate_symbols":[],"type":"Disease","alternate_names":["Funnel chest"],"id":"3285","attribute_content":[],"keywords":[]}
{"medgen_id":"C5200994","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000870\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"615555\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"397685\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000870\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hyperprolactinaemia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000870\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prolactin excess\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000870\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"237662005\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"615555\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Hyperprolactinemia","symbol":"HPRL","alternate_symbols":[],"type":"Disease","alternate_names":["Galactorrhea-Hyperprolactinemia","Galactorrhoea-Hyperprolactinaemia","Hyperprolactinaemia","Prolactin excess"],"id":"6580","attribute_content":[],"keywords":[]}
{"medgen_id":"C0042900","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001045\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008661\"}","{\"db\":\"OMIM\",\"id\":\"193200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"247871\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001045\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Blotchy loss of skin color\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Vitiligo/7406\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001045\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"56727007\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"vitiligo\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"193200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Vitiligo","symbol":"VAMAS6","alternate_symbols":[],"public_definition":"Vitiligo is a condition that causes patchy loss of skin coloring (pigmentation). The average age of onset of vitiligo is in the mid-twenties, but it can appear at any age. It tends to progress over time, with larger areas of the skin losing pigment. Some people with vitiligo also have patches of pigment loss affecting the hair on their scalp or body.Researchers have identified several forms of vitiligo. Generalized vitiligo (also called nonsegmental vitiligo), which is the most common form, involves loss of pigment (depigmentation) in patches of skin all over the body. Depigmentation typically occurs on the face, neck, and scalp, and around body openings such as the mouth and genitals. Sometimes pigment is lost in mucous membranes, such as the lips. Loss of pigmentation is also frequently seen in areas that tend to experience rubbing, impact, or other trauma, such as the hands, arms, and places where bones are close to the skin surface (bony prominences). Another form called segmental vitiligo is associated with smaller patches of depigmented skin that appear on one side of the body in a limited area; this occurs in about 10 percent of affected individuals.Vitiligo is generally considered to be an autoimmune disorder. Autoimmune disorders occur when the immune system attacks the body's own tissues and organs. In people with vitiligo the immune system appears to attack the pigment cells (melanocytes) in the skin. About 15 to 25 percent of people with vitiligo are also affected by at least one other autoimmune disorder, particularly autoimmune thyroid disease, rheumatoid arthritis, type 1 diabetes, psoriasis, pernicious anemia, Addison disease, or systemic lupus erythematosus.In the absence of other autoimmune conditions, vitiligo does not affect general health or physical functioning. However, concerns about appearance and ethnic identity are significant issues for many affected individuals.","type":"Disease","alternate_names":["Blotchy loss of skin color"],"id":"6114","attribute_content":[],"keywords":[]}
{"medgen_id":"C4759712","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001172\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008561\"}","{\"db\":\"OMIM\",\"id\":\"188100\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001172\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of the thumb\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001172\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of the thumbs\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Thumb+deformity/7092\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thumb deformity\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001172\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thumb deformity\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8482\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008561\",\"ref_field\":\"name\"}"],"name":"Thumb deformity (disease)","alternate_symbols":[],"type":"Disease","alternate_names":["Abnormality of the thumb","Abnormality of the thumbs","Thumb absent or hypoplastic","Thumb deformity","Thumb hypoplastic"],"id":"4551","attribute_content":[],"gard_id":"8482","keywords":[]}
{"medgen_id":"C5231391","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001321\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006806\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006910\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007038\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007053\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008939\"}","{\"db\":\"OMIM\",\"id\":\"213000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1398\"}","{\"db\":\"Orphanet\",\"id\":\"2246\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001321\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypoplasia of cerebellum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001321\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypoplastic cerebellum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001321\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Small cerebellum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001321\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Underdeveloped cerebellum\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1194\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001321\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"16026008\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"213000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Congenital cerebellar hypoplasia","symbol":"CHEGDD","alternate_symbols":[],"type":"Disease","alternate_names":["Hypoplasia of cerebellum","Hypoplastic cerebellum","Small cerebellum","Underdeveloped cerebellum"],"id":"4765","attribute_content":[],"gard_id":"1194","keywords":[]}
{"medgen_id":"C0221355","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001355\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"155350\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001355\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macrencephaly\"}","{\"db\":\"SNOMED CT\",\"id\":\"9740002\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macroencephaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001355\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"204070009\",\"ref_field\":\"name\"}"],"name":"Megalencephaly","alternate_symbols":[],"type":"Disease","alternate_names":["Macrencephaly","Macroencephaly"],"id":"2741","attribute_content":[],"keywords":[]}
{"medgen_id":"C0265998","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001798\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007593\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008384\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"206800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"79143\"}","{\"db\":\"OMIM\",\"id\":\"206800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANONYCHIA TOTALIS\"}","{\"db\":\"OMIM\",\"id\":\"206800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANONYCHIA/HYPONYCHIA CONGENITA\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001798\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Absent nails\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001798\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Aplastic nails\"}","{\"db\":\"OMIM\",\"id\":\"206800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"OMIM\",\"id\":\"610573.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"OMIM\",\"id\":\"610573.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"OMIM\",\"id\":\"610573.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"OMIM\",\"id\":\"610573.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"OMIM\",\"id\":\"610573.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"OMIM\",\"id\":\"610573.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"OMIM\",\"id\":\"610573.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"OMIM\",\"id\":\"610573.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Anonychia+Congenita/488\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001798\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"23610003\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"206800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Anonychia","symbol":"NDNC4","alternate_symbols":[],"type":"Disease","alternate_names":["ANONYCHIA TOTALIS","ANONYCHIA/HYPONYCHIA CONGENITA","Absent nails","Aplastic nails","Hyponychia congenita","NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4"],"id":"411","attribute_content":[],"keywords":[]}
{"medgen_id":"C0149931","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002076\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007194\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008000\"}","{\"db\":\"OMIM\",\"id\":\"157300\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002076\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Intermittent migraine headaches\"}","{\"db\":\"OMIM\",\"id\":\"157300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002076\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Migraine headache\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002076\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Migraine headaches\"}","{\"db\":\"OMIM\",\"id\":\"157300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MA\"}","{\"db\":\"OMIM\",\"id\":\"157300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGAU\"}","{\"db\":\"OMIM\",\"id\":\"157300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGR1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Migraine/4811\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002076\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"37796009\",\"ref_field\":\"name\"}"],"name":"Migraine","alternate_symbols":["MA","MGAU","MGR1"],"type":"Disease","alternate_names":["Intermittent migraine headaches","MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1","Migraine Disorders","Migraine headache","Migraine headaches"],"id":"5538","attribute_content":[],"keywords":[]}
{"medgen_id":"C3277226","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002091\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002111\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002111\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Restrictive deficit on pulmonary function testing\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002111\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Restrictive deficit on pulmonary function tests\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002091\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Restrictive lung disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002111\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Restrictive respiratory disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002111\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Restrictive respiratory insufficiency'\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002111\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Restrictive respiratory syndrome\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002091\",\"ref_field\":\"name\"}"],"name":"Restrictive ventilatory defect","alternate_symbols":[],"type":"Finding","alternate_names":["Restrictive deficit on pulmonary function testing","Restrictive deficit on pulmonary function tests","Restrictive lung disease","Restrictive respiratory disease","Restrictive respiratory insufficiency'","Restrictive respiratory syndrome"],"id":"22843","attribute_content":[],"keywords":[]}
{"medgen_id":"C0268553","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002161\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009388\"}","{\"db\":\"OMIM\",\"id\":\"238700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2203\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002161\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Elevated blood lysine\"}","{\"db\":\"OMIM\",\"id\":\"238700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLYSINEMIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"605113.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLYSINEMIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"605113.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLYSINEMIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"605113.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLYSINEMIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"605113.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLYSINEMIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"605113.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLYSINEMIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"605113.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLYSINEMIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"605113.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERLYSINEMIA, TYPE I\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2828\",\"ref_field\":\"gard_id\"}","{\"db\":\"GeneTests\",\"id\":\"22217\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hyperlysinemia/3579\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002161\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"58558003\",\"ref_field\":\"name\"}"],"name":"Hyperlysinemia","alternate_symbols":[],"type":"Disease","alternate_names":["Alpha-aminoadipic semialdehyde synthase deficiency","Elevated blood lysine","HYPERLYSINEMIA, TYPE I","Hyperlysinemias","L-lysine NAD-oxido-reductase deficiency","Lysine alpha-ketoglutarate reductase deficiency","Lysine intolerance"],"id":"5286","attribute_content":[],"gard_id":"2828","keywords":[]}
{"medgen_id":"C0033680","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002243\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009174\"}","{\"db\":\"OMIM\",\"id\":\"226300\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002243\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Protein-losing enteropathy\"}","{\"db\":\"OMIM\",\"id\":\"226300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CHAPLE\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009174\",\"ref_field\":\"name\"}"],"name":"Protein-losing enteropathy (disease)","alternate_symbols":["CHAPLE"],"type":"Disease","alternate_names":["Protein-Losing Enteropathies","Protein-losing enteropathy"],"id":"2087","attribute_content":[],"keywords":[]}
{"medgen_id":"C5231392","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002343\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009366\"}","{\"db\":\"OMIM\",\"id\":\"236690\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"314928\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Normal+Pressure+Hydrocephalus/5268\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002343\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"30753002\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"236690\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Normal pressure hydrocephalus","symbol":"HYDNP1","alternate_symbols":[],"type":"Disease","alternate_names":[],"id":"2345","attribute_content":[],"keywords":[]}
{"medgen_id":"C0700153","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002486\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003632\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003754\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003792\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002486\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed relaxation of muscle fibers after contraction\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002486\",\"ref_field\":\"name\"}"],"name":"Myotonia","alternate_symbols":[],"type":"Finding","alternate_names":["Delayed relaxation of muscle fibers after contraction"],"id":"23102","attribute_content":[],"keywords":[]}
{"medgen_id":"C1849156","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002497\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"270500\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"PS108600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"316226\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002497\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS108600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"],"name":"Spastic ataxia","alternate_symbols":[],"type":"Disease","alternate_names":["Ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and mental retardation"],"id":"4156","attribute_content":[],"keywords":[]}
{"medgen_id":"C0040588","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002575\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"189960\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1199\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Tracheoesophageal+fistula/7156\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002575\",\"ref_field\":\"name\"}"],"name":"Tracheoesophageal fistula","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301753\",\"@Source\":\"PubMed\"},{\"$\":\"NBK5192\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"type":"Finding","alternate_names":["Esophageal atresia with or without tracheoesophageal fistula"],"id":"23162","attribute_content":[],"keywords":[]}
{"medgen_id":"C0038015","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002655\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002776\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005893\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008471\"}","{\"db\":\"OMIM\",\"id\":\"183900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"94068\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002655\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spondyloepiphyseal dysplasia\"}","{\"db\":\"OMIM\",\"id\":\"183900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SEDC\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4987\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondyloepiphyseal+dysplasia+congenita/6821\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008471\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"183900\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}"],"name":"Spondyloepiphyseal dysplasia congenita","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31021589\",\"@Source\":\"PubMed\"},{\"$\":\"NBK540447\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["SEDC"],"public_definition":"Spondyloepiphyseal dysplasia congenita is an autosomal dominant chondrodysplasia characterized by disproportionate short stature (short trunk), abnormal epiphyses, and flattened vertebral bodies. Skeletal features are manifested at birth and evolve with time. Other features include myopia and/or retinal degeneration with retinal detachment and cleft palate (summary by Anderson et al., 1990).","type":"Disease","alternate_names":["SED congenita","Spondyloepiphyseal dysplasia","Spondyloepiphyseal dysplasia, congenital type"],"id":"4455","attribute_content":[],"gard_id":"4987","keywords":[]}
{"medgen_id":"C4759767","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002657\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"184250\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93346\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondyloepimetaphyseal+dysplasia+Strudwick+type/6814\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spondyloepimetaphyseal dysplasia Strudwick type\"}","{\"db\":\"OMIM\",\"id\":\"184250\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SEMDC\"}","{\"db\":\"OMIM\",\"id\":\"184250\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SMD\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002657\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184250\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Spondylometaphyseal dysplasia","symbol":"SEMDSTWK","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31021589\",\"@Source\":\"PubMed\"},{\"$\":\"NBK540447\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["SEMDC","SMD"],"type":"Disease","alternate_names":["Dappled metaphysis syndrome","SMED Strudwick type","SMED type 1","Spondyloepimetaphyseal dysplasia Strudwick type","Strudwick syndrome"],"id":"4453","attribute_content":[],"keywords":[]}
{"medgen_id":"C0029463","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002669\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0002629\"}","{\"db\":\"MeSH\",\"id\":\"D012516\"}","{\"db\":\"OMIM\",\"id\":\"259500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"668\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002669\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Osteogenic sarcoma\"}","{\"db\":\"OMIM\",\"id\":\"259500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OSRC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Osteosarcoma/5489\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002669\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"21708004\",\"ref_field\":\"name\"}"],"name":"Osteosarcoma","alternate_symbols":["OSRC"],"type":"Disease","alternate_names":["Osteogenic sarcoma","Osteosarcoma, somatic"],"id":"3682","attribute_content":[],"keywords":[]}
{"medgen_id":"C5241445","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002974\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003962\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0017985\"}","{\"db\":\"OMIM\",\"id\":\"179300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3269\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002974\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fused forearm bones\"}","{\"db\":\"OMIM\",\"id\":\"179300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"602931.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Congenital+radio-ulnar+synostosis/9645\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002974\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"33313004\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"179300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Radioulnar synostosis","symbol":"RUS","alternate_symbols":[],"type":"Disease","alternate_names":["Fused forearm bones","RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO"],"id":"3573","attribute_content":[],"keywords":[]}
{"medgen_id":"C0268624","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003643\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010089\"}","{\"db\":\"OMIM\",\"id\":\"272300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"833\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Sulfite+oxidase+deficiency/6924\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Sulfite oxidase deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Sulfite oxidase deficiency\"}","{\"db\":\"SNOMED CT\",\"id\":\"367368009\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Sulfite oxidase deficiency\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010089\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK453433\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"272300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Isolated sulfite oxidase deficiency","symbol":"ISOD","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"28933809\",\"@Source\":\"PubMed\"},{\"$\":\"NBK453433\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"The spectrum of isolated sulfite oxidase deficiency ranges from classic early-onset (severe) disease to late-onset (mild) disease. Classic ISOD is characterized in the first few hours to days of life by intractable seizures, feeding difficulties, and rapidly progressive encephalopathy manifest as abnormal tone (especially opisthotonus, spastic quadriplegia, and pyramidal signs) followed by progressive microcephaly and profound intellectual disability. Lens subluxation or dislocation, another characteristic finding, may be evident after the newborn period. Children usually die during the first few months of life. Late-onset ISOD manifests between ages six and 18 months and is characterized by ectopia lentis (variably present), developmental delay/regression, movement disorder characterized by dystonia and choreoathetosis, ataxia, and (rarely) acute hemiplegia due to metabolic stroke. The clinical course may be progressive or episodic. In the episodic form encephalopathy, dystonia, choreoathetosis, and/or ataxia are intermittent.","type":"Disease","alternate_names":["Sulfite oxidase deficiency","Sulfocysteinuria"],"id":"3860","attribute_content":[],"keywords":[]}
{"medgen_id":"C5193007","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003737\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008960\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009637\"}","{\"db\":\"OMIM\",\"id\":\"251900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"206966\"}","{\"db\":\"OMIM\",\"id\":\"251900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"11956\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mitochondrial+myopathy/8902\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003737\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1224\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"251900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Mitochondrial myopathy","symbol":"MEOAL","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301403\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1224\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. They can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA (mtDNA). While some mitochondrial disorders only affect a single organ (e.g., the eye in Leber hereditary optic neuropathy [LHON]), many involve multiple organ systems and often present with prominent neurologic and myopathic features. Mitochondrial disorders may present at any age. Many individuals with a mutation of mtDNA display a cluster of clinical features that fall into a discrete clinical syndrome, such as the Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), myoclonic epilepsy with ragged-red fibers (MERRF), neurogenic weakness with ataxia and retinitis pigmentosa (NARP), or Leigh syndrome (LS). However, considerable clinical variability exists and many individuals do not fit neatly into one particular category, which is well-illustrated by the overlapping spectrum of disease phenotypes (including mitochondrial recessive ataxia syndrome (MIRAS) resulting from mutation of the nuclear gene POLG, which has emerged as a major cause of mitochondrial disease. Common clinical features of mitochondrial disease – whether involving a mitochondrial or nuclear gene – include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Common central nervous system findings are fluctuating encephalopathy, seizures, dementia, migraine, stroke-like episodes, ataxia, and spasticity. A high incidence of mid- and late pregnancy loss is a common occurrence that often goes unrecognized.","type":"Disease","alternate_names":["MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY","Mitochondrial Myopathies"],"id":"2957","attribute_content":[],"gard_id":"11956","keywords":[]}
{"medgen_id":"C0743332","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004373\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007140\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"611284\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Focal+Dystonia/2887\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004373\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"611284\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Focal dystonia","symbol":"FTSD","alternate_symbols":[],"type":"Finding","alternate_names":["Focal task specific dystonia"],"id":"24405","attribute_content":[],"keywords":[]}
{"medgen_id":"C0010273","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004439\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007405\"}","{\"db\":\"MeSH\",\"id\":\"D003394\"}","{\"db\":\"OMIM\",\"id\":\"123500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"207\"}","{\"db\":\"OMIM\",\"id\":\"123500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CRANIOFACIAL DYSOSTOSIS, TYPE I\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004439\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Craniofacial dysostosis\"}","{\"db\":\"OMIM\",\"id\":\"123500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CFD1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6206\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Crouzon+Syndrome/2018\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004439\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"28861008\",\"ref_field\":\"name\"}"],"name":"Crouzon syndrome","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301628\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1455\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111019\",\"@Source\":\"pmc\"}}]}","alternate_symbols":["CFD1"],"type":"Disease","alternate_names":["CRANIOFACIAL DYSOSTOSIS, TYPE I","Craniofacial dysostosis","Craniofacial dysostosis type 1","Crouzon craniofacial dysostosis","Crouzon disease"],"id":"4878","attribute_content":[],"gard_id":"6206","keywords":[]}
{"medgen_id":"C1833340","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004443\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004486\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010929\"}","{\"db\":\"OMIM\",\"id\":\"600775\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004443\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lambdoid suture craniosynostosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004443\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lambdoid suture synostosis\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Lambdoid+synostosis/4076\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lambdoid synostosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004443\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lambdoidal craniosynostosis\"}","{\"db\":\"OMIM\",\"id\":\"600775\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CRS4\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010929\",\"ref_field\":\"name\"}"],"name":"Craniosynostosis 4","alternate_symbols":["CRS4"],"type":"Disease","alternate_names":["Lambdoid suture craniosynostosis","Lambdoid suture synostosis","Lambdoid synostosis","Lambdoidal craniosynostosis"],"id":"2534","attribute_content":[],"keywords":[]}
{"medgen_id":"C0264885","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004764\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004764\",\"ref_field\":\"name\"}"],"name":"Myxomatous mitral valve degeneration","alternate_symbols":[],"type":"Finding","alternate_names":[],"id":"24613","attribute_content":[],"keywords":[]}
{"medgen_id":"C0409957","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006233\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"140600\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"140600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HAND OSTEOARTHRITIS\"}","{\"db\":\"OMIM\",\"id\":\"140600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS\"}","{\"db\":\"OMIM\",\"id\":\"140600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOARTHRITIS SUSCEPTIBILITY 2\"}","{\"db\":\"OMIM\",\"id\":\"602109.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOARTHRITIS SUSCEPTIBILITY 2\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006233\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Osteoarthritis of the distal interphalangeal joint\"}","{\"db\":\"OMIM\",\"id\":\"140600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DIPOA\"}","{\"db\":\"OMIM\",\"id\":\"140600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HOA\"}","{\"db\":\"OMIM\",\"id\":\"140600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OADIP\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Osteoarthritis+of+distal+interphalangeal+joint/9048\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"239869009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"140600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Osteoarthritis of distal interphalangeal joint","symbol":"OS2","alternate_symbols":["DIPOA","HOA","OADIP"],"type":"Disease","alternate_names":["HAND OSTEOARTHRITIS","OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS","OSTEOARTHRITIS SUSCEPTIBILITY 2","Osteoarthritis of the distal interphalangeal joint"],"id":"5694","attribute_content":[],"keywords":[]}
{"medgen_id":"C0206682","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006731\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"188470\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"188470\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THYROID CANCER, NONMEDULLARY, 2\"}","{\"db\":\"OMIM\",\"id\":\"606523.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THYROID CANCER, NONMEDULLARY, 2\"}","{\"db\":\"OMIM\",\"id\":\"606523.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THYROID CANCER, NONMEDULLARY, 2\"}","{\"db\":\"OMIM\",\"id\":\"606523.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THYROID CANCER, NONMEDULLARY, 2, SUSCEPTIBILITY TO\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Thyroid+cancer%2C+follicular/7105\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thyroid cancer, follicular\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006731\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188470\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Follicular thyroid carcinoma","symbol":"NMTC2","content":"{\"Citation\":{\"@Abbrev\":\"AHRQ, 2013\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin\"},\"URL\":{\"$\":\"https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf\"}}}","alternate_symbols":["FTC"],"type":"Disease","alternate_names":["THYROID CANCER, NONMEDULLARY, 2","THYROID CANCER, NONMEDULLARY, 2, SUSCEPTIBILITY TO","Thyroid cancer, follicular","Thyroid carcinoma, follicular, somatic"],"id":"6052","attribute_content":[],"keywords":[]}
{"medgen_id":"C0002736","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007354\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0004976\"}","{\"db\":\"OMIM\",\"id\":\"PS105400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"803\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007354\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lou gehrig's disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007354\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS105400\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"86044005\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"amyotrophic-lateral-sclerosis\",\"ref_field\":\"public_definition\"}"],"name":"Amyotrophic lateral sclerosis","symbol":"ALS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301623\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1450\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21914052\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Orphanet, 2007\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Orphanet, Amyotrophic lateral sclerosis, 2007\"},\"URL\":{\"$\":\"https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf\"}}]}","alternate_symbols":[],"public_definition":"Amyotrophic lateral sclerosis (ALS) is a progressive disease that affects motor neurons, which are specialized nerve cells that control muscle movement. These nerve cells are found in the spinal cord and the brain. In ALS, motor neurons die (atrophy) over time, leading to muscle weakness, a loss of muscle mass, and an inability to control movement.There are many different types of ALS; these types are distinguished by their signs and symptoms and their genetic cause or lack of clear genetic association. Most people with ALS have a form of the condition that is described as sporadic, which means it occurs in people with no apparent history of the disorder in their family. People with sporadic ALS usually first develop features of the condition in their late fifties or early sixties. A small proportion of people with ALS, estimated at 5 to 10 percent, have a family history of ALS or a related condition called frontotemporal dementia (FTD), which is a progressive brain disorder that affects personality, behavior, and language. The signs and symptoms of familial ALS typically first appear in one's late forties or early fifties. Rarely, people with familial ALS develop symptoms in childhood or their teenage years. These individuals have a rare form of the disorder known as juvenile ALS.The first signs and symptoms of ALS may be so subtle that they are overlooked. The earliest symptoms include muscle twitching, cramping, stiffness, or weakness. Affected individuals may develop slurred speech (dysarthria) and, later, difficulty chewing or swallowing (dysphagia). Many people with ALS experience malnutrition because of reduced food intake due to dysphagia and an increase in their body's energy demands (metabolism) due to prolonged illness. Muscles become weaker as the disease progresses, and arms and legs begin to look thinner as muscle tissue atrophies. Individuals with ALS eventually lose muscle strength and the ability to walk. Affected individuals eventually become wheelchair-dependent and increasingly require help with personal care and other activities of daily living. Over time, muscle weakness causes affected individuals to lose the use of their hands and arms. Breathing becomes difficult because the muscles of the respiratory system weaken. Most people with ALS die from respiratory failure within 2 to 10 years after the signs and symptoms of ALS first appear; however, disease progression varies widely among affected individuals.Approximately 20 percent of individuals with ALS also develop FTD. Changes in personality and behavior may make it difficult for affected individuals to interact with others in a socially appropriate manner. Communication skills worsen as the disease progresses. It is unclear how the development of ALS and FTD are related. Individuals who develop both conditions are diagnosed as having ALS-FTD.A rare form of ALS that often runs in families is known as ALS-parkinsonism-dementia complex (ALS-PDC). This disorder is characterized by the signs and symptoms of ALS, in addition to a pattern of movement abnormalities known as parkinsonism, and a progressive loss of intellectual function (dementia). Signs of parkinsonism include unusually slow movements (bradykinesia), stiffness, and tremors. Affected members of the same family can have different combinations of signs and symptoms.","type":"Disease","alternate_names":["Charcot disease","Lou Gehrig disease","Lou gehrig's disease"],"id":"9457","attribute_content":[],"keywords":[]}
{"medgen_id":"C0152422","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007707\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012456\"}","{\"db\":\"OMIM\",\"id\":\"610256\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"83461\"}","{\"db\":\"OMIM\",\"id\":\"601094.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANTERIOR SEGMENT DYSGENESIS 2\"}","{\"db\":\"OMIM\",\"id\":\"601094.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANTERIOR SEGMENT DYSGENESIS 2\"}","{\"db\":\"OMIM\",\"id\":\"601094.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANTERIOR SEGMENT DYSGENESIS 2\"}","{\"db\":\"OMIM\",\"id\":\"610256\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANTERIOR SEGMENT DYSGENESIS 2\"}","{\"db\":\"OMIM\",\"id\":\"610256\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CPA\"}","{\"db\":\"OMIM\",\"id\":\"610256\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CPAK\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9952\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007707\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610256\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Congenital primary aphakia","symbol":"ASGD2","alternate_symbols":["CPA","CPAK"],"type":"Disease","alternate_names":["ANTERIOR SEGMENT DYSGENESIS 2"],"id":"423","attribute_content":[],"gard_id":"9952","keywords":[]}
{"medgen_id":"C0266537","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007971\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007290\"}","{\"db\":\"OMIM\",\"id\":\"116800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"OMIM\",\"id\":\"602438.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 5, LAMELLAR\"}","{\"db\":\"OMIM\",\"id\":\"602438.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 5, LAMELLAR\"}","{\"db\":\"OMIM\",\"id\":\"602438.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 5, LAMELLAR\"}","{\"db\":\"OMIM\",\"id\":\"116800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT, MARNER TYPE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract%2C+Zonular/1162\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cataract, zonular\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007971\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital lamellar cataracts\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007971\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lamellar cataract\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007290\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"116800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Cataract 5 multiple types","symbol":"CTRCT5","alternate_symbols":[],"type":"Disease","alternate_names":["CATARACT 5, LAMELLAR","CATARACT, MARNER TYPE","Cataract, zonular","Congenital lamellar cataracts","Lamellar cataract","Perinuclear cataract"],"id":"4749","attribute_content":[],"keywords":[]}
{"medgen_id":"C1563716","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008188\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0024264\"}","{\"db\":\"OMIM\",\"id\":\"218700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"95712\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008188\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thyroid dysgenesis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008188\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thyroid dysplasia\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0024264\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"218700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Hypothyroidism, congenital, nongoitrous, 2","symbol":"CHNG2","alternate_symbols":[],"type":"Disease","alternate_names":["Thyroid dysgenesis","Thyroid dysplasia","Thyroid, ectopic"],"id":"5311","attribute_content":[],"keywords":[]}
{"medgen_id":"C1271219","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009918\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007515\"}","{\"db\":\"OMIM\",\"id\":\"129750\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009918\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Corectopia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009918\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Displaced pupil\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009918\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ectopia pupillae\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8490\",\"ref_field\":\"gard_id\"}","{\"db\":\"SNOMED CT\",\"id\":\"392461003\",\"ref_field\":\"name\"}"],"name":"Congenital ectopic pupil","alternate_symbols":[],"type":"Disease","alternate_names":["Congenital eye malformation in which the pupils are displaced from their normal central position","Corectopia","Displaced pupil","Ectopia pupillae","Familial ectopic pupil"],"id":"4998","attribute_content":[],"gard_id":"8490","keywords":[]}
{"medgen_id":"C4759698","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010296\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007125\"}","{\"db\":\"OMIM\",\"id\":\"106280\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010296\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ankyloglossia\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007125\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ankyloglossia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010296\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Tongue tied\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010296\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"67787004\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"106280\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Tongue tie","symbol":"ANKG","alternate_symbols":[],"type":"Disease","alternate_names":["Ankyloglossia","Tongue tied"],"id":"318","attribute_content":[],"keywords":[]}
{"medgen_id":"C0022548","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010562\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007847\"}","{\"db\":\"OMIM\",\"id\":\"148100\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010562\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Keloids\"}"],"name":"Keloid formation","alternate_symbols":[],"type":"Disease","alternate_names":["Keloids"],"id":"1886","attribute_content":[],"keywords":[]}
{"medgen_id":"C0029421","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010886\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0017178\"}","{\"db\":\"OMIM\",\"id\":\"165800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"251262\"}","{\"db\":\"OMIM\",\"id\":\"165800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010886\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Osteochondrosis dissecans\"}","{\"db\":\"OMIM\",\"id\":\"165800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS\"}","{\"db\":\"OMIM\",\"id\":\"165800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4133\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Osteochondritis+dissecans/5443\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"82562007\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"165800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Osteochondritis dissecans","symbol":"SSOAOD","alternate_symbols":["OD"],"type":"Disease","alternate_names":["OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS","Osteochondrosis dissecans","SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS"],"id":"3326","attribute_content":[],"gard_id":"4133","keywords":["Neoplasm"]}
{"medgen_id":"C0524524","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010922\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007284\"}","{\"db\":\"OMIM\",\"id\":\"116100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010922\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Membranous cataract\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007284\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"116100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Cataract 20 multiple types","symbol":"CTRCT20","alternate_symbols":[],"type":"Disease","alternate_names":["Membranous cataract"],"id":"4751","attribute_content":[],"keywords":[]}
{"medgen_id":"C0342388","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011748\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008720\"}","{\"db\":\"OMIM\",\"id\":\"201400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"199296\"}","{\"db\":\"OMIM\",\"id\":\"201400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH DEFICIENCY, ISOLATED\"}","{\"db\":\"OMIM\",\"id\":\"604614.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH DEFICIENCY, ISOLATED\"}","{\"db\":\"OMIM\",\"id\":\"604614.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH DEFICIENCY, ISOLATED\"}","{\"db\":\"OMIM\",\"id\":\"604614.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH DEFICIENCY, ISOLATED\"}","{\"db\":\"OMIM\",\"id\":\"604614.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH DEFICIENCY, ISOLATED\"}","{\"db\":\"OMIM\",\"id\":\"604614.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH DEFICIENCY, ISOLATED\"}","{\"db\":\"Genetic Alliance\",\"id\":\"ACTH+Deficiency/175\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011748\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH deficiency\"}","{\"db\":\"SNOMED CT\",\"id\":\"237692001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTH deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011748\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Corticotropin deficiency\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5727\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011748\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"201400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Adrenocorticotropic hormone deficiency","symbol":"IAD","alternate_symbols":[],"type":"Disease","alternate_names":["ACTH DEFICIENCY, ISOLATED","ACTH deficiency","Corticotropin deficiency","Nocturnal Frontal Lobe Epilepsy, Autosomal Dominant"],"id":"24","attribute_content":[],"gard_id":"5727","keywords":[]}
{"medgen_id":"C4225503","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012205\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007060\"}","{\"db\":\"OMIM\",\"id\":\"102530\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"171709\"}","{\"db\":\"OMIM\",\"id\":\"102530\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACROSOME MALFORMATION OF SPERMATOZOA\"}","{\"db\":\"OMIM\",\"id\":\"102530\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ROUND-HEADED SPERMATOZOA\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007060\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spermatogenic failure 6\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spermatogenic+failure+6/9326\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012205\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"236818008\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"102530\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Globozoospermia","symbol":"SPGF6","alternate_symbols":[],"type":"Disease","alternate_names":["ACROSOME MALFORMATION OF SPERMATOZOA","ROUND-HEADED SPERMATOZOA","Spermatogenic failure 6"],"id":"1377","attribute_content":[],"keywords":[]}
{"medgen_id":"C0403397","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012588\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0044765\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012588\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"236381000 \",\"ref_field\":\"name\"}"],"name":"Steroid-resistant nephrotic syndrome","alternate_symbols":[],"type":"Finding","alternate_names":[],"id":"30468","attribute_content":[],"keywords":[]}
{"medgen_id":"C0522129","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012617\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012617\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Red blood cell casts\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012617\",\"ref_field\":\"name\"}"],"name":"Erythrocyte cylindruria","alternate_symbols":[],"type":"Finding","alternate_names":["Red blood cell casts"],"id":"30497","attribute_content":[],"keywords":[]}
{"medgen_id":"C1840452","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030673\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007740\"}","{\"db\":\"OMIM\",\"id\":\"143200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"898\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK3821\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"VCAN-Related Vitreoretinopathy\"}","{\"db\":\"OMIM\",\"id\":\"118661.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"118661.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"118661.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"118661.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"118661.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"118661.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"118661.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"118661.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"143200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"WAGNER VITREORETINOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"143200\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ERVR\"}","{\"db\":\"OMIM\",\"id\":\"143200\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"WGVRP\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7871\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Wagner+syndrome/7430\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"wagner-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"232064001\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK3821\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"143200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Wagner syndrome","symbol":"WGN1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301747\",\"@Source\":\"PubMed\"},{\"$\":\"NBK3821\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["ERVR","VCAN","WGVRP"],"public_definition":"VCAN-related vitreoretinopathy, which includes Wagner syndrome and erosive vitreoretinopathy (ERVR), is characterized by \"optically empty vitreous\" on slit-lamp examination and avascular vitreous strands and veils, mild or occasionally moderate to severe myopia, presenile cataract, night blindness of variable degree associated with progressive chorioretinal atrophy, retinal traction and retinal detachment in the advanced stages of disease, and reduced visual acuity. Optic nerve inversion as well as uveitis has also been described. Systemic abnormalities are not observed. The first signs usually become apparent during early adolescence, but onset can be as early as age two years.","type":"Disease","alternate_names":["Hyaloideoretinal degeneration of Wagner","VCAN-Related Vitreoretinopathy","WAGNER VITREORETINOPATHY","Wagner disease (formerly)","Wagner syndrome type 1","Wagner vitreoretinal degeneration"],"id":"3962","attribute_content":[],"gard_id":"7871","keywords":[]}
{"medgen_id":"C1562061","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030961\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"251750\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"238763\"}","{\"db\":\"OMIM\",\"id\":\"251750\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA\"}","{\"db\":\"OMIM\",\"id\":\"602091.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA\"}","{\"db\":\"OMIM\",\"id\":\"602091.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA\"}","{\"db\":\"OMIM\",\"id\":\"602091.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA\"}","{\"db\":\"OMIM\",\"id\":\"602091.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA\"}","{\"db\":\"OMIM\",\"id\":\"602091.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA\"}","{\"db\":\"OMIM\",\"id\":\"602091.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Microspherophakia/8884\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030961\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"416671000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"251750\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Microspherophakia","symbol":"MSPKA","alternate_symbols":[],"type":"Disease","alternate_names":["MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA"],"id":"2801","attribute_content":[],"keywords":[]}
{"medgen_id":"C0027794","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045005\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"182940\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3388\"}","{\"db\":\"Orphanet\",\"id\":\"823\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045005\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of neural tube closure\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Neural+tube+defects/8992\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045005\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"253098009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"182940\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Neural tube defect","symbol":"NTD","alternate_symbols":[],"type":"Disease","alternate_names":["Abnormality of neural tube closure","Neural tube defects"],"id":"3168","attribute_content":[],"keywords":["Neoplasm"]}
{"medgen_id":"C4551852","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100252\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007542\"}","{\"db\":\"OMIM\",\"id\":\"131300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1328\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1156\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Camurati-Engelmann Disease\"}","{\"db\":\"OMIM\",\"id\":\"131300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CED\"}","{\"db\":\"OMIM\",\"id\":\"131300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DPD1\"}","{\"db\":\"OMIM\",\"id\":\"131300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PDD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1072\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Diaphyseal+dysplasia/8235\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100252\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"34643004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1156\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"131300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Diaphyseal dysplasia","symbol":"CAEND","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301335\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1156\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["CED","DPD1","PDD"],"public_definition":"Camurati-Engelmann disease (CED) is characterized by hyperostosis of the long bones and the skull, proximal muscle weakness, limb pain, a wide-based, waddling gait, and joint contractures. Facial features such as macrocephaly, frontal bossing, enlargement of the mandible, proptosis, and cranial nerve impingement resulting in facial palsy are seen in severely affected individuals later in life.","type":"Disease","alternate_names":["Camurati-Engelmann Disease","Diaphyseal dysplasia 1, progressive","Engelmann disease","Progressive diaphyseal dysplasia"],"id":"1077","attribute_content":[],"gard_id":"1072","keywords":[]}
{"medgen_id":"C0919267","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100615\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0021068\"}","{\"db\":\"MeSH\",\"id\":\"D010051\"}","{\"db\":\"OMIM\",\"id\":\"167000\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100615\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Neoplasm of the ovaries\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100615\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Neoplasm of the ovary\"}","{\"db\":\"OMIM\",\"id\":\"116806.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN CANCER, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"164730.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN CANCER, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"164870.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN CANCER, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"192090.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN CANCER, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"600098.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN CANCER, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"600632.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN CANCER, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"602544.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN CANCER, SOMATIC\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100615\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ovarian neoplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100615\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ovarian neoplasm\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100615\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ovarian tumor\"}","{\"db\":\"SNOMED CT\",\"id\":\"123843001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ovarian tumor\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Neoplasm+of+ovary/8972\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"123843001\",\"ref_field\":\"name\"}"],"name":"Neoplasm of ovary","content":"{\"Citation\":[{\"@Abbrev\":\"NACB, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19042984\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2012\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"22964825\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23188549\",\"@Source\":\"PubMed\"}}]}","alternate_symbols":[],"type":"Disease","alternate_names":["Neoplasm of the ovaries","Neoplasm of the ovary","OVARIAN CANCER, SOMATIC","Ovarian Neoplasms","Ovarian neoplasia","Ovarian neoplasm","Ovarian tumor"],"id":"5713","attribute_content":[],"keywords":[]}
{"medgen_id":"C0018213","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100647\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0005364\"}","{\"db\":\"OMIM\",\"id\":\"275000\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Graves%27+Disease/3178\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Graves' disease\"}","{\"db\":\"OMIM\",\"id\":\"275000\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERTHYROIDISM, AUTOIMMUNE\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100647\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Morbus Basedow\"}","{\"db\":\"OMIM\",\"id\":\"275000\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THYROTOXICOSIS\"}","{\"db\":\"OMIM\",\"id\":\"275000\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GRD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6549\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100647\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"275000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Graves disease","symbol":"GRD1","alternate_symbols":["GRD"],"type":"Disease","alternate_names":["Basedow disease","Exophthalmic goiter","Graves' disease","Graves' hyperthyroidism","HYPERTHYROIDISM, AUTOIMMUNE","Morbus Basedow","Parry disease","THYROTOXICOSIS"],"id":"1399","attribute_content":[],"gard_id":"6549","keywords":[]}
{"medgen_id":"C0036220","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100726\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"148000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"33276\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Classic+Kaposi+Sarcoma/1655\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Classic Kaposi sarcoma\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100726\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Kaposi's sarcoma\"}","{\"db\":\"OMIM\",\"id\":\"148000\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MULTIPLE IDIOPATHIC PIGMENTED HEMANGIOSARCOMA, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"148000\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}"],"name":"Kaposi sarcoma, susceptibility to","alternate_symbols":["HHV8","KSHV"],"public_definition":"Kaposi sarcoma (KS) is an invasive angioproliferative inflammatory condition that occurs commonly in men infected with human immunodeficiency virus (HIV; see 609423). In the early stages of KS, lesions appear reactive and are stimulated to grow by the actions of inflammatory cytokines and growth factors. In the late stages of KS, a malignant phenotype that appears to be monoclonal can develop. Infection with human herpesvirus-8 (HHV-8), also known as KS-associated herpesvirus (KSHV), is necessary but not sufficient for KS development. Coinfection with HIV markedly increases the likelihood of KS development, and additional environmental, hormonal, and genetic cofactors likely contribute to its pathogenesis (summary by Foster et al., 2000).\r\nSuthaus et al. (2012) noted that HHV-8 is the etiologic agent not only of KS, but also of primary effusion lymphoma and plasma cell-type multicentric Castleman disease (MCD).","type":"Disease","alternate_names":["Classic Kaposi sarcoma","Human herpesvirus 8","Kaposi's sarcoma","MULTIPLE IDIOPATHIC PIGMENTED HEMANGIOSARCOMA, SUSCEPTIBILITY TO","Mediterranean Kaposi sarcoma","Non AIDS related Kaposi sarcoma"],"id":"2506","attribute_content":[],"keywords":[]}
{"medgen_id":"C0033117","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200023\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"176620\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200023\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"hulseyism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Priapism/5933\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200023\",\"ref_field\":\"name\"}"],"name":"Priapism","alternate_symbols":[],"type":"Finding","alternate_names":["Priapism, familial idiopathic","hulseyism"],"id":"31722","attribute_content":[],"keywords":[]}
{"medgen_id":"C0376175","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000296\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000302\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000344\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000353\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002008\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002259\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002517\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004670\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007212\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200004\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cranial nerve VII palsy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial muscle weakness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial muscle weakness of muscles innervated by CN VII\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial nerve palsy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial nerve paralysis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial palsy, unilateral or bilateral\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial weakness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Seventh cranial nerve palsy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"VII th cranial nerve palsy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"name\"}"],"name":"Facial palsy","alternate_symbols":[],"type":"Finding","alternate_names":["Antoni's palsy","Bell palsy","Cranial nerve VII palsy","Facial cranial nerve paralysis","Facial muscle weakness","Facial muscle weakness of muscles innervated by CN VII","Facial nerve palsy","Facial nerve paralysis","Facial palsy, unilateral or bilateral","Facial weakness","Idiopathic facial palsy","Refrigeration palsy","Seventh cranial nerve palsy","VII th cranial nerve palsy"],"id":"28559","attribute_content":[],"keywords":[]}
{"medgen_id":"C5194606","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000948\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005002\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005636\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005704\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006427\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100255\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009943\"}","{\"db\":\"OMIM\",\"id\":\"265900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3005\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100255\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Metaphyseal dysplasia\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0009943\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pyle disease\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4612\",\"ref_field\":\"gard_id\"}","{\"db\":\"SNOMED CT\",\"id\":\"27837003\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"265900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Pyle metaphyseal dysplasia","symbol":"PYL","alternate_symbols":[],"type":"Disease","alternate_names":["Metaphyseal dysplasia","Pyle disease","Pyle's disease"],"id":"3585","attribute_content":[],"gard_id":"4612","keywords":[]}
{"medgen_id":"C0029408","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001379\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002758\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002824\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005762\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"165720\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002758\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Degenerative joint disease\"}","{\"db\":\"OMIM\",\"id\":\"165720\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOARTHRITIS OF HIP, FEMALE-SPECIFIC, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"165720\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOARTHROSIS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Osteoarthritis+susceptibility+1/9050\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Osteoarthritis susceptibility 1\"}","{\"db\":\"OMIM\",\"id\":\"165720\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OA\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002758\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"165720\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Osteoarthritis","symbol":"OS1","alternate_symbols":["OA"],"type":"Disease","alternate_names":["Degenerative joint disease","OSTEOARTHRITIS OF HIP, FEMALE-SPECIFIC, SUSCEPTIBILITY TO","OSTEOARTHROSIS","Osteoarthritis susceptibility 1"],"id":"5693","attribute_content":[],"keywords":[]}
{"medgen_id":"C0242584","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001936\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001973\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004806\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004829\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"188030\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3002\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Idiopathic thrombocytopenia\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Idiopathic+thrombocytopenic+purpura/3760\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Idiopathic thrombocytopenic purpura\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Idiopathic thrombocytopenic purpura\"}","{\"db\":\"SNOMED CT\",\"id\":\"32273002\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Idiopathic thrombocytopenic purpura\"}","{\"db\":\"OMIM\",\"id\":\"188030\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ITP\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001973\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"immune-thrombocytopenia\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"188030\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Autoimmune thrombocytopenia","symbol":"AITP","alternate_symbols":["ITP"],"public_definition":"Immune thrombocytopenia is a disorder characterized by a blood abnormality called thrombocytopenia, which is a shortage of blood cells called platelets that are needed for normal blood clotting.Affected individuals can develop red or purple spots on the skin caused by bleeding just under the skin's surface. Small spots of bleeding under the skin are called purpura and larger spots are called ecchymoses. People with immune thrombocytopenia can have significant bleeding episodes, such as nose bleeds (epistaxis) or bleeding in the moist lining (mucosae) of the mouth. In severe cases, individuals may have gastrointestinal bleeding or blood in the urine or stool, or heavy and prolonged menstrual bleeding (menorrhagia). In very rare instances, bleeding inside the skull (intracranial hemorrhage) can occur, which can be life-threatening. A greater reduction in platelet numbers is often associated with more frequent bleeding episodes and an increased risk of severe bleeding.While immune thrombocytopenia can be diagnosed at any age, there are two periods when the condition is most likely to develop: early childhood and late adulthood. In children, the reduction in platelets is often sudden, but platelet levels usually return to normal levels within weeks to months. Immune thrombocytopenia in children is often preceded by a minor infection, such as an upper respiratory infection, but the relationship between the infection and immune thrombocytopenia is not clear. In adults, the development of immune thrombocytopenia is usually gradual and the condition tends to persist throughout life.","type":"Disease","alternate_names":["Autoimmune thrombocytopenic purpura","Idiopathic thrombocytopenia","Idiopathic thrombocytopenic purpura"],"id":"22748","attribute_content":[],"keywords":[]}
{"medgen_id":"C0232411","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002237\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002291\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004522\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004538\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008070\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008070\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thin, sparse hair\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008070\",\"ref_field\":\"name\"}"],"name":"Sparse hair","alternate_symbols":[],"type":"Finding","alternate_names":["Thin, sparse hair"],"id":"26589","attribute_content":[],"keywords":[]}
{"medgen_id":"C5234937","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003289\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003294\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004315\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005394\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008325\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008340\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0045045\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased IgG level\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased gamma-globin expression\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased immunoglobulin G\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased serum IgG\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004315\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Reduced IgG levels\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10371\",\"ref_field\":\"gard_id\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004315\",\"ref_field\":\"name\"}"],"name":"IgG deficiency","alternate_symbols":[],"type":"Finding","alternate_names":["Decreased IgG level","Decreased gamma-globin expression","Decreased immunoglobulin G","Decreased serum IgG","Reduced IgG levels"],"id":"24355","attribute_content":[],"gard_id":"10371","keywords":[]}
{"medgen_id":"C5235039","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003290\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003568\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003568\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Phosphohexose isomerase deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003568\",\"ref_field\":\"name\"}"],"name":"Decreased glucosephosphate isomerase activity","alternate_symbols":[],"type":"Finding","alternate_names":["Phosphohexose isomerase deficiency"],"id":"23876","attribute_content":[],"keywords":[]}
{"medgen_id":"C4551903","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005153\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005160\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005175\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011626\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007130\"}","{\"db\":\"OMIM\",\"id\":\"106700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99125\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pulmonary+venous+return+anomaly/6098\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulmonary venous return anomaly\"}","{\"db\":\"OMIM\",\"id\":\"106700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005160\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Total anomalous pulmonary venous connection\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005160\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Total anomalous pulmonary venous drainage\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005160\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Total anomalous pulmonary venous return\"}","{\"db\":\"OMIM\",\"id\":\"106700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"APVR\"}","{\"db\":\"OMIM\",\"id\":\"106700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TAPVR1\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007130\",\"ref_field\":\"name\"}"],"name":"Congenital total pulmonary venous return anomaly","alternate_symbols":["APVR","TAPVR","TAPVR1"],"type":"Disease","alternate_names":["Pulmonary venous return anomaly","TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1","Total anomalous pulmonary venous connection","Total anomalous pulmonary venous drainage","Total anomalous pulmonary venous return"],"id":"3910","attribute_content":[],"keywords":[]}
{"medgen_id":"C0022665","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005933\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009726\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0021163\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0021163\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Kidney neoplasm\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009726\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Neoplasia of the kidneys\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009726\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal neoplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009726\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal tumors\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009726\",\"ref_field\":\"name\"}"],"name":"Renal neoplasm","alternate_symbols":[],"type":"Finding","alternate_names":["Kidney neoplasm","Neoplasia of the kidneys","Renal neoplasia","Renal tumors"],"id":"17294","attribute_content":[],"keywords":[]}
{"medgen_id":"C0011860","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005965\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100652\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0005148\"}","{\"db\":\"MeSH\",\"id\":\"D003924\"}","{\"db\":\"OMIM\",\"id\":\"125853\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"125853\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST\"}","{\"db\":\"OMIM\",\"id\":\"600733.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"600733.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"600733.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"600733.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"600733.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"600733.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Diabetes mellitus Type II\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NIDDM diabetes mellitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Non-insulin dependent diabetes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Noninsulin-dependent diabetes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Noninsulin-dependent diabetes mellitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type 2 diabetes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type II diabetes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NIDDM\"}","{\"db\":\"OMIM\",\"id\":\"125853\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NIDDM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Diabetes+mellitus+type+2/8215\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005978\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"44054006\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"125853\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Type 2 diabetes mellitus","symbol":"T2D","content":"{\"Citation\":[{\"@Abbrev\":\"PLoS Currents, 2011\",\"@Type\":\"general\",\"URL\":{\"$\":\"http://knol.google.com/k/raluca-mihaescu/genetic-risk-profiling-for-prediction/20113liwenx5c/9?collectionId=28qm4w0q65e4w.50#\"}},{\"@Abbrev\":\"EGAPP, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23492873\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ES, 2012\",\"@Type\":\"practice guideline\",\"ID\":[{\"$\":\"22962670\",\"@Source\":\"PubMed\"},{\"$\":\"3431581\",\"@Source\":\"pmc\"}]}]}","alternate_symbols":["NIDDM"],"type":"Disease","alternate_names":["DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST","DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO","Diabetes mellitus Type II","NIDDM diabetes mellitus","Non-insulin dependent diabetes","Noninsulin-dependent diabetes","Noninsulin-dependent diabetes mellitus","Type 2 diabetes","Type II diabetes"],"id":"4949","attribute_content":[],"keywords":[]}
{"medgen_id":"C4759728","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008809\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008843\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"612400\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008843\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hip osteoarthritis\"}","{\"db\":\"OMIM\",\"id\":\"601146.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOARTHRITIS SUSCEPTIBILITY 5\"}","{\"db\":\"OMIM\",\"id\":\"612400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOARTHRITIS SUSCEPTIBILITY 5\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Osteoarthritis+of+hip/9049\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008843\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"239872002\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Osteoarthritis of hip","symbol":"OS5","alternate_symbols":[],"type":"Disease","alternate_names":["Hip osteoarthritis","OSTEOARTHRITIS SUSCEPTIBILITY 5"],"id":"3130","attribute_content":[],"keywords":[]}
{"disease_mechanism":"gain of function","medgen_id":"C3281201","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0007617\"}","{\"db\":\"OMIM\",\"id\":\"135900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1465\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypertrichosis%2C+hyperkeratosis%2C+mental+retardation%2C+and+distinctive+facial+features/3617\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypertrichosis, hyperkeratosis, mental retardation, and distinctive facial features\"}","{\"db\":\"Genetic Alliance\",\"id\":\"MENTAL+RETARDATION%2C+AUTOSOMAL+DOMINANT+12/8820\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mental retardation, autosomal dominant 12\"}","{\"db\":\"OMIM\",\"id\":\"135900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRD12\"}","{\"db\":\"OMIM\",\"id\":\"614562\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRD12\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000309827\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501263\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506306\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508459\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508460\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510938\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527930\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561944\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK131811\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"135900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Coffin-Siris syndrome 1","symbol":"CSS1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23556151\",\"@Source\":\"PubMed\"},{\"$\":\"NBK131811\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31132234\",\"@Source\":\"PubMed\"},{\"$\":\"NBK541502\",\"@Source\":\"BookShelf\"}]}]}","alternate_symbols":["MRD12"],"public_definition":"Coffin-Siris syndrome (CSS) is classically characterized by aplasia or hypoplasia of the distal phalanx or nail of the fifth and additional digits, developmental or cognitive delay of varying degree, distinctive facial features, hypotonia, hirsutism/hypertrichosis, and sparse scalp hair. Congenital anomalies can include malformations of the cardiac, gastrointestinal, genitourinary, and/or central nervous systems. Other findings commonly include feeding difficulties, slow growth, ophthalmologic abnormalities, and hearing impairment.","type":"Disease","disease_mechanism_id":"274","alternate_names":["Hypertrichosis, hyperkeratosis, mental retardation, and distinctive facial features","Mental retardation, autosomal dominant 12"],"id":"824","attribute_content":[],"keywords":["Neoplasm"]}
{"disease_mechanism":"gain of function","medgen_id":"C0085261","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008318\"}","{\"db\":\"OMIM\",\"id\":\"176920\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"744\"}","{\"db\":\"OMIM\",\"id\":\"164730.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROTEUS SYNDROME, SOMATIC\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508960\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515803\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520081\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528059\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528379\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528912\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7475\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Proteus+syndrome/6005\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"proteus-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"23150001\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK99495\",\"ref_field\":\"public_definition\"}"],"name":"Proteus syndrome","content":"{\"Citation\":[{\"@Abbrev\":\"Biesecker et al., 1998\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"10360391\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Turner et al., 2004\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"15372514\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Lindhurst et al., 2011\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"21793738\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22876373\",\"@Source\":\"PubMed\"},{\"$\":\"NBK99495\",\"@Source\":\"BookShelf\"}]}]}","alternate_symbols":[],"public_definition":"Proteus syndrome is characterized by progressive segmental or patchy overgrowth most commonly affecting the skeleton, skin, adipose, and central nervous systems. In most individuals Proteus syndrome has modest or no manifestations at birth, develops and progresses rapidly beginning in the toddler period, and relentlessly progresses through childhood, causing severe overgrowth and disfigurement. It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism.","type":"Disease","disease_mechanism_id":"274","alternate_names":["Elattoproteus syndrome","Gigantism, partial, of hands and feet, nevi, hemihypertrophy, and macrocephaly","Hemihypertrophy and macrocephaly","Macrocephaly mesodermal hamartoma spectrum","PROTEUS SYNDROME, SOMATIC","Partial gigantism of hands and feet, nevi, hemihypertrophy, macrocephaly"],"id":"4046","attribute_content":["{\"Attribute\":{\"$\":\"loss of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"273\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000551654\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000552540\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000570020\"}]}"],"gard_id":"7475","keywords":["Hereditary cancer syndrome","Neoplasm"]}
{"disease_mechanism":"gain of function","medgen_id":"C3160733","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008559\"}","{\"db\":\"OMIM\",\"id\":\"188050\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"188050\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO FACTOR 2 DEFECT\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500305\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"F2\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000025288\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000174333\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321099\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000331922\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000331933\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332126\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502122\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502510\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503192\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507481\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509249\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511144\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520021\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520078\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521336\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521660\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530629\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531243\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552060\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556387\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10815\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008559\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188050\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Thrombophilia due to thrombin defect","symbol":"THPH1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301327\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1148\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["F2"],"type":"Finding","disease_mechanism_id":"274","alternate_names":["Prothrombin-Related Thrombophilia (Factor II)","THROMBOPHILIA DUE TO FACTOR 2 DEFECT","Thrombosis susceptibility"],"id":"24727","attribute_content":["{\"Attribute\":{\"$\":\"loss of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"273\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000525921\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000323271\"}]}"],"gard_id":"10815","keywords":[]}
{"disease_mechanism":"gain of function","medgen_id":"C5393570","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011643\"}","{\"db\":\"OMIM\",\"id\":\"606176\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99885\"}","{\"db\":\"OMIM\",\"id\":\"606176\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PDMI\"}","{\"db\":\"OMIM\",\"id\":\"606176\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PNDM1\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000284792\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500516\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500517\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506518\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506519\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506524\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508859\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514676\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514677\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514687\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514688\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514689\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552542\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552543\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552544\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552549\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556820\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556824\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556831\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556834\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000557910\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558434\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000559250\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10457\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Permanent+neonatal+diabetes+mellitus/5681\",\"ref_field\":\"name\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0011643\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1447\",\"ref_field\":\"public_definition\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000284792\",\"ref_field\":\"symbol\"}"],"name":"Permanent neonatal diabetes mellitus","symbol":"PNDM","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301620\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1447\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":["PDMI","PNDM1"],"public_definition":"Permanent neonatal diabetes mellitus (PNDM) is characterized by the onset of hyperglycemia within the first six months of life (mean age: 7 weeks; range: birth to 26 weeks). The diabetes mellitus is associated with partial or complete insulin deficiency. Clinical manifestations at the time of diagnosis include intrauterine growth retardation, hyperglycemia, glycosuria, osmotic polyuria, severe dehydration, and failure to thrive. Therapy with insulin corrects the hyperglycemia and results in dramatic catch-up growth. The course of PNDM varies by genotype.","type":"Disease","disease_mechanism_id":"274","alternate_names":["Permanent diabetes mellitus of infancy"],"id":"1095","attribute_content":[],"gard_id":"10457","keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C1861171","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008560\"}","{\"db\":\"OMIM\",\"id\":\"188055\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"188055\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACTIVATED PROTEIN C RESISTANCE\"}","{\"db\":\"OMIM\",\"id\":\"188055\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"APC RESISTANCE\"}","{\"db\":\"OMIM\",\"id\":\"188055\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PCCF DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"188055\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROC COFACTOR DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"188055\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO DEFICIENCY OF ACTIVATED PROTEIN C COFACTOR\"}","{\"db\":\"OMIM\",\"id\":\"188055\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA V\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000024913\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"5FLE\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000174331\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000320550\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332439\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502535\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509324\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521336\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531243\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562501\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Thrombophilia+due+to+activated+protein+C+resistance/9393\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1368\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"188055\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Thrombophilia due to activated protein C resistance","symbol":"THPH2","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301542\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1368\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACOG, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20027064\",\"@Source\":\"PubMed\"}}]}","alternate_symbols":["5FLE","THPH1"],"public_definition":"Factor V Leiden thrombophilia is characterized by a poor anticoagulant response to activated protein C (APC) and an increased risk for venous thromboembolism (VTE). Deep vein thrombosis (DVT) is the most common VTE, with the legs being the most common site. Thrombosis in unusual locations is less common. Evidence suggests that heterozygosity for the Leiden variant has at most a modest effect on risk for recurrent thrombosis after initial treatment of a first VTE. It is unlikely that factor V Leiden thrombophilia (i.e., heterozygosity or homozygosity for the Leiden variant) is a major factor contributing to pregnancy loss and other adverse pregnancy outcomes (preeclampsia, fetal growth restriction, and placental abruption). The clinical expression of factor V Leiden thrombophilia is influenced by the following: The number of Leiden variants (heterozygotes have a slightly increased risk for venous thrombosis; homozygotes have a much greater thrombotic risk). Coexisting genetic thrombophilic disorders, which have a supra-additive effect on overall thrombotic risk. Acquired thrombophilic disorders: antiphospholipid antibody (APLA) syndrome, paroxysmal nocturnal hemoglobinuria, myeloproliferative disorders, and increased levels of clotting factors. Circumstantial risk factors including but not limited to pregnancy, central venous catheters, travel, combined oral contraceptive (COC) use and other combined contraceptives, oral hormone replacement therapy (HRT), selective estrogen receptor modulators (SERMs), obesity, leg injury, and advancing age.","type":"Disease","disease_mechanism_id":"273","alternate_names":["ACTIVATED PROTEIN C RESISTANCE","APC RESISTANCE","PCCF DEFICIENCY","PROC COFACTOR DEFICIENCY","THROMBOPHILIA DUE TO DEFICIENCY OF ACTIVATED PROTEIN C COFACTOR","THROMBOPHILIA V"],"id":"4548","attribute_content":["{\"Attribute\":{\"$\":\"gain of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"274\"},\"XRef\":{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000325434\"}}"],"keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C0220704","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008644\"}","{\"db\":\"OMIM\",\"id\":\"192430\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"567\"}","{\"db\":\"OMIM\",\"id\":\"192430\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHROMOSOME 22q11.2 DELETION SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"192430\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"VCF SYNDROME\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0008644\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Velocardiofacial syndrome\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000013538\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332446\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000335344\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501119\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506067\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520911\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529038\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531722\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556723\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"SNOMED CT\",\"id\":\"83092002\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1523\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"192430\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Shprintzen syndrome","symbol":"VCFS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301696\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1523\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"Int'l 22q11.2 Del Syndrome Consortium, 2011\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3197829\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGenetest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"2987430\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"Fung et al., 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25569435\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"27467454\",\"@Source\":\"PubMed\"}}]}","alternate_symbols":[],"public_definition":"Individuals with 22q11.2 deletion syndrome (22q11.2DS) can present with a wide range of features that are highly variable, even within families. The major clinical manifestations of 22q11.2DS include congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus), palatal abnormalities (velopharyngeal incompetence, submucosal cleft palate, bifid uvula, and cleft palate), immune deficiency, characteristic facial features, and learning difficulties. Hearing loss can be sensorineural and/or conductive. Laryngotracheoesophageal, gastrointestinal, ophthalmologic, central nervous system, skeletal, and genitourinary anomalies also occur. Psychiatric illness and autoimmune disorders are more common in individuals with 22q11.2DS.","type":"Disease","disease_mechanism_id":"273","alternate_names":["CHROMOSOME 22q11.2 DELETION SYNDROME","Shprintzen VCF syndrome","Takao vcf syndrome","VCF SYNDROME","VCF syndome","Velocardiofacial syndrome"],"id":"4485","attribute_content":[],"keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C0019562","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0008667\"}","{\"db\":\"OMIM\",\"id\":\"193300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"892\"}","{\"db\":\"OMIM\",\"id\":\"193300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"VHL\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000314230\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528276\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552165\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553527\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553528\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562500\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569658\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7855\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Von+Hippel-Lindau+syndrome/7416\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"46659004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1463\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"193300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Von Hippel-Lindau syndrome","symbol":"VHLS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301636\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1463\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ES, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24893135\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NANETS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3419007\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG/NSGC, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25394175\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"KCRNC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24319509\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","alternate_symbols":["VHL"],"public_definition":"Von Hippel-Lindau (VHL) syndrome is characterized by hemangioblastomas of the brain, spinal cord, and retina; renal cysts and clear cell renal cell carcinoma; pheochromocytoma, pancreatic cysts, and neuroendocrine tumors; endolymphatic sac tumors; and epididymal and broad ligament cysts. Cerebellar hemangioblastomas may be associated with headache, vomiting, gait disturbances, or ataxia. Spinal hemangioblastomas and related syrinx usually present with pain. Sensory and motor loss may develop with cord compression. Retinal hemangioblastomas may be the initial manifestation of VHL syndrome and can cause vision loss. Renal cell carcinoma occurs in about 70% of individuals with VHL and is the leading cause of mortality. Pheochromocytomas can be asymptomatic but may cause sustained or episodic hypertension. Pancreatic lesions often remain asymptomatic and rarely cause endocrine or exocrine insufficiency. Endolymphatic sac tumors can cause hearing loss of varying severity, which can be a presenting symptom. Cystadenomas of the epididymis are relatively common. They rarely cause problems, unless bilateral, in which case they may result in infertility.","type":"Disease","disease_mechanism_id":"273","alternate_names":["VHL syndrome"],"id":"6116","attribute_content":[],"gard_id":"7855","keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C2676676","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011450\"}","{\"db\":\"OMIM\",\"id\":\"604370\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"145\"}","{\"db\":\"OMIM\",\"id\":\"604370\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0020\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0023\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0024\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0025\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0026\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0027\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0028\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0029\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0030\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0031\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0032\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0033\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0034\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0035\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0036\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0037\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0038\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0040\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0041\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"113705.0042\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"604370\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"602667.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN CANCER, SUSCEPTIBILITY TO\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501743\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HBOC\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000017876\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000021517\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000320777\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325409\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332529\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501743\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501746\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501817\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000505644\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507653\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507764\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507864\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509001\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509002\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509450\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509692\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509980\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512320\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512644\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512645\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512816\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514601\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519030\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520069\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520071\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520072\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520866\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520867\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520871\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520872\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521908\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522159\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522160\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522161\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527942\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528915\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531275\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551440\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552304\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562228\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569406\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569423\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Breast-ovarian+cancer%2C+familial+1/7865\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1247\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"604370\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Breast-ovarian cancer, familial 1","symbol":"BROVCA1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301425\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1247\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACS, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17392385\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2010\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"20065170\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17508274\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACOG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19305347\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Phillips et al., 2013\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"23918944\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Domchek et al., 2010\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"2948529\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24366376\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23188549\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG/NSGC, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25394175\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24366402\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24432435\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]},{\"@Abbrev\":\"NCCN, 2013\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian\"},\"URL\":{\"$\":\"http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf\"}}]}","alternate_symbols":["HBOC"],"public_definition":"BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.","type":"Disease","disease_mechanism_id":"273","alternate_names":["BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","Breast cancer, familial 1","OVARIAN CANCER, SUSCEPTIBILITY TO"],"id":"4711","attribute_content":[],"keywords":["Neoplasm"]}
{"disease_mechanism":"loss of function","medgen_id":"C1838547","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0011713\"}","{\"db\":\"OMIM\",\"id\":\"606719\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"404560\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325625\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501426\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502978\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569524\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Melanoma-pancreatic+cancer+syndrome/8812\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606719\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}"],"name":"Melanoma-pancreatic cancer syndrome","content":"{\"Citation\":[{\"@Abbrev\":\"CAPS, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3585492\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACG, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25645574\",\"@Source\":\"PubMed\"}}]}","alternate_symbols":[],"public_definition":"Melanoma-pancreatic cancer syndrome is an inherited cancer predisposition syndrome in which mutation carriers have an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer (summary by Harinck et al., 2012).\r\nFor background and phenotypic information on malignant melanoma and pancreatic cancer, see 155600 and 260350, respectively.","type":"Disease","disease_mechanism_id":"273","alternate_names":[],"id":"2742","attribute_content":[],"keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C3552553","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012880\"}","{\"db\":\"OMIM\",\"id\":\"612370\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"478\"}","{\"db\":\"OMIM\",\"id\":\"608892.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPHIC HYPOGONADISM 5 WITHOUT ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"608892.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 5 WITH ANOSMIA\"}","{\"db\":\"OMIM\",\"id\":\"608892.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGONADOTROPIC HYPOGONADISM 5 WITH ANOSMIA\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Kallmann+syndrome+5/8704\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Kallmann syndrome 5\"}","{\"db\":\"OMIM\",\"id\":\"612370\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HH5\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000334133\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506067\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556729\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556733\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558347\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10773\",\"ref_field\":\"gard_id\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0012880\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1334\",\"ref_field\":\"public_definition\"}"],"name":"Hypogonadotropic hypogonadism 5 with or without anosmia","symbol":"KAL5","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301296\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1117\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301509\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1334\",\"@Source\":\"BookShelf\"}]}]}","alternate_symbols":["HH5"],"public_definition":"Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., \u003c4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.","type":"Disease","disease_mechanism_id":"273","alternate_names":["CHD7-Related Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency","HYPOGONADOTROPHIC HYPOGONADISM 5 WITHOUT ANOSMIA","HYPOGONADOTROPIC HYPOGONADISM 5 WITH ANOSMIA","Kallmann syndrome 5"],"id":"5355","attribute_content":[],"gard_id":"10773","keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C2675520","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0012933\"}","{\"db\":\"OMIM\",\"id\":\"612555\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"145\"}","{\"db\":\"OMIM\",\"id\":\"612555\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"600185.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"OMIM\",\"id\":\"612555\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501818\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BRCA2\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501744\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HBOC\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000017874\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000021468\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000320777\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325401\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000326160\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332529\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501744\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501748\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501818\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000505644\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507653\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507764\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507864\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509001\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509002\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509450\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509692\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509980\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509985\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512644\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512645\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512816\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519030\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520069\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520071\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520072\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520866\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520867\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520871\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520872\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522159\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522160\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527942\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528915\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530707\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531275\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531340\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551447\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552304\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562228\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569406\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569423\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Breast-ovarian+cancer%2C+familial+2/7866\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1247\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612555\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Breast-ovarian cancer, familial 2","symbol":"BROVCA2","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301425\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1247\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACS, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17392385\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2010\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"20065170\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17508274\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACOG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19305347\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Phillips et al., 2013\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"23918944\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Domchek et al., 2010\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"2948529\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24366376\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CAPS, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3585492\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23188549\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG/NSGC, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25394175\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2014\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24366402\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"USPSTF, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24432435\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]},{\"@Abbrev\":\"NCCN, 2013\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"National Comprehensive Cancer Network practice guidelines in oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian\"},\"URL\":{\"$\":\"http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf\"}}]}","alternate_symbols":["BRCA2","HBOC"],"public_definition":"BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (includes fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The exact cancer risks differ slightly depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.","type":"Disease","disease_mechanism_id":"273","alternate_names":["BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2","BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2","Breast cancer, familial 2"],"id":"636","attribute_content":[],"keywords":["Neoplasm"]}
{"disease_mechanism":"loss of function","medgen_id":"C0268342","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0016002\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1900\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EDS VI\"}","{\"db\":\"OMIM\",\"id\":\"153454.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"153454.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, OCULAR-SCOLIOTIC TYPE\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, TYPE VI\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, TYPE VIA\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EDS6\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EDS6A\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500398\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509007\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510821\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514633\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515704\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522328\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525812\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529376\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561718\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Ehlers-Danlos+syndrome%2C+hydroxylysine-deficient/8298\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Nevo+syndrome/5215\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"25606004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1462\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"225400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Ehlers-Danlos syndrome, hydroxylysine-deficient","symbol":"EDSKSCL1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301635\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1462\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"2987428\",\"@Source\":\"pmc\"}}]}","alternate_symbols":["EDS6","EDS6A"],"public_definition":"PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an autosomal recessive generalized connective tissue disorder characterized by hypotonia, early-onset kyphoscoliosis, and generalized joint hypermobility in association with skin fragility and ocular abnormality. Intelligence is normal. Life span may be normal, but affected individuals are at risk for rupture of medium-sized arteries. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure.","type":"Disease","disease_mechanism_id":"273","alternate_names":["Cerebral gigantism nevo type","EDS VI","EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1","EHLERS-DANLOS SYNDROME, OCULAR-SCOLIOTIC TYPE","EHLERS-DANLOS SYNDROME, TYPE VI","EHLERS-DANLOS SYNDROME, TYPE VIA","Ehlers-Danlos Syndrome, Kyphoscoliotic Form","Ehlers-Danlos syndrome kyphoscoliotic type","Ehlers-Danlos syndrome type 6 (formerly)","Nevo syndrome"],"id":"1586","attribute_content":[],"keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C1333990","xrefs":["{\"db\":\"MONDO\",\"id\":\"MONDO:0018630\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332533\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568362\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568365\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"lynch-syndrome\",\"ref_field\":\"public_definition\"}"],"name":"Hereditary nonpolyposis colon cancer","symbol":"HNPCC","alternate_symbols":[],"public_definition":"Lynch syndrome, often called hereditary nonpolyposis colorectal cancer (HNPCC), is an inherited disorder that increases the risk of many types of cancer, particularly cancers of the colon (large intestine) and rectum, which are collectively referred to as colorectal cancer. People with Lynch syndrome also have an increased risk of cancers of the stomach, small intestine, liver, gallbladder ducts, urinary tract, brain, and skin. Additionally, women with this disorder have a high risk of cancer of the ovaries and lining of the uterus (endometrial cancer). Women with Lynch syndrome have a higher overall risk of developing cancer than men with the condition because of these cancers of the female reproductive system. Individuals with Lynch syndrome typically develop cancer in their forties or fifties.People with Lynch syndrome may occasionally have noncancerous (benign) growths in the colon, called colon polyps. In individuals with this disorder, colon polyps occur at a younger age but not in greater numbers than they do in the general population.","type":"Disease","disease_mechanism_id":"273","alternate_names":["Hereditary nonpolyposis colorectal cancer"],"id":"53477","attribute_content":[],"keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C5194182","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001935\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"206200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"209981\"}","{\"db\":\"OMIM\",\"id\":\"206200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH DEFECT IN IRON METABOLISM\"}","{\"db\":\"OMIM\",\"id\":\"206200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IRON-HANDLING DISORDER, HEREDITARY\"}","{\"db\":\"OMIM\",\"id\":\"206200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSEUDO-IRON-DEFICIENCY ANEMIA\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500228\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500397\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508489\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Microcytic+anemia/8872\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001935\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"234349007\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"206200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Microcytic anemia","symbol":"IRIDA","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","alternate_names":["ANEMIA, HYPOCHROMIC MICROCYTIC, WITH DEFECT IN IRON METABOLISM","IRON-HANDLING DISORDER, HEREDITARY","PSEUDO-IRON-DEFICIENCY ANEMIA"],"id":"1873","attribute_content":[],"keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C1527284","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003771\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0007437\"}","{\"db\":\"OMIM\",\"id\":\"125420\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1653\"}","{\"db\":\"Orphanet\",\"id\":\"99791\"}","{\"db\":\"OMIM\",\"id\":\"125420\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANOMALOUS DYSPLASIA OF DENTIN\"}","{\"db\":\"OMIM\",\"id\":\"125420\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DENTIN DYSPLASIA, SHIELDS TYPE II\"}","{\"db\":\"OMIM\",\"id\":\"125420\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DENTIN DYSPLASIA, TYPE II\"}","{\"db\":\"OMIM\",\"id\":\"125485.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DENTIN DYSPLASIA, TYPE II\"}","{\"db\":\"OMIM\",\"id\":\"125485.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DENTIN DYSPLASIA, TYPE II\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003771\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"False denticles\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003771\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"False pulp stones\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003771\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulp calcifications\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003771\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulp denticles\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003771\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulp stones\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003771\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"True denticles\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003771\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"True pulp stones\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000324339\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1806\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Denticles/8209\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"57602001\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"125420\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Denticles","symbol":"DTDP2","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","alternate_names":["ANOMALOUS DYSPLASIA OF DENTIN","DENTIN DYSPLASIA, SHIELDS TYPE II","DENTIN DYSPLASIA, TYPE II","Dental Pulp Stone","Dentin dyspalsia, Shields type 2","Dentin dysplasia, coronal","False denticles","False pulp stones","Pulp calcifications","Pulp denticles","Pulp stones","Pulpal dysplasia","True denticles","True pulp stones"],"id":"4935","attribute_content":[],"gard_id":"1806","keywords":[]}
{"disease_mechanism":"loss of function","medgen_id":"C0016952","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004919\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0018116\"}","{\"db\":\"Orphanet\",\"id\":\"352\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004919\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Galactose intolerance\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569081\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591289\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000591986\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000592259\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2424\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Galactosemia/2973\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"190745006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1518\",\"ref_field\":\"public_definition\"}"],"name":"Galactosemia","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301691\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1518\",\"@Source\":\"BookShelf\"}]}}","alternate_symbols":[],"public_definition":"The term \"galactosemia\" refers to disorders of galactose metabolism that include classic galactosemia, clinical variant galactosemia, and biochemical variant galactosemia. This GeneReview focuses on: Classic galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage, bleeding, and E coli sepsis in untreated infants. If a lactose-restricted diet is provided during the first ten days of life, the neonatal signs usually quickly resolve and the complications of liver failure, sepsis, and neonatal death are prevented; however, despite adequate treatment from an early age, children with classic galactosemia remain at increased risk for developmental delays, speech problems (termed childhood apraxia of speech and dysarthria), and abnormalities of motor function. Almost all females with classic galactosemia manifest premature ovarian insufficiency (POI). Clinical variant galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage including cirrhosis, and bleeding in untreated infants. This is exemplified by the disease that occurs in African Americans and native Africans in South Africa. Persons with clinical variant galactosemia may be missed with newborn screening (NBS) as the hypergalactosemia is not as marked as in classic galactosemia and breath testing is normal. If a lactose-restricted diet is provided during the first ten days of life, the severe acute neonatal complications are usually prevented. African Americans with clinical variant galactosemia and adequate early treatment do not appear to be at risk for long-term complications including POI.","type":"Disease","disease_mechanism_id":"273","alternate_names":["Galactose intolerance"],"id":"16954","attribute_content":[],"gard_id":"2424","keywords":[]}
{"disease_mechanism":"Constitutively activated FLT3","medgen_id":"C0023467","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001914\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004808\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004843\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005516\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006724\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006728\",\"type\":\"secondary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0018874\"}","{\"db\":\"MeSH\",\"id\":\"D015470\"}","{\"db\":\"OMIM\",\"id\":\"601626\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"519\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004808\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Acute myeloblastic leukemia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004808\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Acute myelocytic leukemia\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Acute+Myeloid+Leukemia%2C+Adult/204\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Acute myelogenous leukemia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004808\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Acute myelogenous leukemia\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552464\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004808\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"519\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"17788007\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK47457\",\"ref_field\":\"public_definition\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500636\",\"ref_field\":\"symbol\"}","{\"db\":\"OMIM\",\"id\":\"601626\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"],"name":"Acute myeloid leukemia","symbol":"AML","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20963938\",\"@Source\":\"PubMed\"},{\"$\":\"NBK47457\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"NCCN, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"22138009\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESMO, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23970018\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"33226740\",\"@Source\":\"PubMed\"},{\"$\":\"NBK564234\",\"@Source\":\"BookShelf\"}]}]}","alternate_symbols":[],"public_definition":"CEBPA-associated familial acute myeloid leukemia (AML) is defined as AML in which a heterozygous germline CEBPA pathogenic variant is present in a family in which multiple individuals have AML. In contrast, sporadic CEBPA-associated AML is defined as AML in which a CEBPA pathogenic variant(s) is identified in leukemic cells but not in the non-leukemic cells. Too few individuals with CEBPA-associated familial AML have been reported to be certain about the natural history of the disease. In the majority of individuals, the age of onset of familial AML appears to be earlier than sporadic AML; disease onset has been reported in persons as young as age 1.8 years and older than age 45 years. The prognosis of CEBPA-associated familial AML appears to be favorable compared with sporadic CEBPA-associated AML. Individuals with CEBPA-associated familial AML who have been cured of their initial disease may be at greater risk of developing additional independent leukemic episodes in addition to the risk of relapse due to preexisting clones.","type":"Disease","alternate_names":["AML adult","Acute granulocytic leukemia","Acute myeloblastic leukemia","Acute myelocytic leukemia","Acute myelogenous leukemia","Acute myeloid leukemia, adult","Acute non-lymphocytic leukemia","Leukemia, acute myelogenous, somatic","Leukemia, acute myeloid, somatic"],"id":"15736","attribute_content":[],"keywords":[]}
{"disease_mechanism":"Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.","medgen_id":"C0002986","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"type\":\"primary\"}","{\"db\":\"MONDO\",\"id\":\"MONDO:0010526\"}","{\"db\":\"OMIM\",\"id\":\"301500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"324\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Angiokeratoma corporis diffusum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fabry+Disease/2690\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"SNOMED CT\",\"id\":\"16652001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500007\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6400\",\"ref_field\":\"gard_id\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"fabry-disease\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1292\",\"ref_field\":\"public_definition\"}"],"name":"Fabry disease","content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"3009617\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301469\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1292\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"HFSA, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20610207\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"12735292\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Eng et al., 2006\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"16980809\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Salviati et al, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"2869001\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21934708\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AHA/ASA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25355838\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23860966\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","alternate_symbols":[],"public_definition":"Fabry disease results from deficient activity of the enzyme alpha-galactosidase A (a-Gal A) and progressive lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. The classic form, occurring in males with less than 1% a-Gal A enzyme activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesia), the appearance of vascular cutaneous lesions (angiokeratomas), sweating abnormalities (anhidrosis, hypohidrosis, and rarely hyperhidrosis), characteristic corneal and lenticular opacities, and proteinuria. Gradual deterioration of renal function to end-stage renal disease (ESRD) usually occurs in men in the third to fifth decade. In middle age, most males successfully treated for ESRD develop cardiac and/or cerebrovascular disease, a major cause of morbidity and mortality. Heterozygous females typically have milder symptoms at a later age of onset than males. Rarely, they may be relatively asymptomatic throughout a normal life span or may have symptoms as severe as those observed in males with the classic phenotype. In contrast, males with greater than 1% a-Gal A activity may have: (1) a cardiac variant phenotype that usually presents in the sixth to eighth decade with left ventricular hypertrophy, cardiomyopathy and arrhythmia, and proteinuria, but without ESRD; or (2) a renal variant phenotype, associated with ESRD but without the skin lesions or pain; or (3) cerebrovascular disease presenting as stroke or transient ischemic attack.","type":"Disease","alternate_names":["Alpha-galactosidase A deficiency","Anderson-Fabry disease","Angiokeratoma corporis diffusum","Angiokeratoma, diffuse","Ceramide trihexosidase deficiency","Ceramide trihexosidosis","Fabry syndrome","Fabry's disease","GLA deficiency","Hereditary dystopic lipidosis"],"id":"1790","attribute_content":["{\"Attribute\":{\"$\":\"loss of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"273\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000514924\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520414\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528516\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000551442\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000505068\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507480\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507942\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000522527\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000568367\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000591289\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000246735\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000260631\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520063\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520447\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528528\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000552214\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556520\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000558532\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000325415\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000512526\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528276\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528500\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528536\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556501\"}]}"],"gard_id":"6400","keywords":[]}
